Reprogramming of fatty acid metabolism in cancer
A common feature of cancer cells is their ability to rewire their metabolism to sustain the production of ATP and macromolecules needed for cell growth, division and survival. In particular, the importance of altered fatty acid metabolism in cancer has received renewed interest as, aside their princ...
Uložené v:
| Vydané v: | British journal of cancer Ročník 122; číslo 1; s. 4 - 22 |
|---|---|
| Hlavní autori: | , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
Nature Publishing Group UK
01.01.2020
Nature Publishing Group |
| Predmet: | |
| ISSN: | 0007-0920, 1532-1827, 1532-1827 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | A common feature of cancer cells is their ability to rewire their metabolism to sustain the production of ATP and macromolecules needed for cell growth, division and survival. In particular, the importance of altered fatty acid metabolism in cancer has received renewed interest as, aside their principal role as structural components of the membrane matrix, they are important secondary messengers, and can also serve as fuel sources for energy production. In this review, we will examine the mechanisms through which cancer cells rewire their fatty acid metabolism with a focus on four main areas of research. (1) The role of de novo synthesis and exogenous uptake in the cellular pool of fatty acids. (2) The mechanisms through which molecular heterogeneity and oncogenic signal transduction pathways, such as PI3K–AKT–mTOR signalling, regulate fatty acid metabolism. (3) The role of fatty acids as essential mediators of cancer progression and metastasis, through remodelling of the tumour microenvironment. (4) Therapeutic strategies and considerations for successfully targeting fatty acid metabolism in cancer. Further research focusing on the complex interplay between oncogenic signalling and dysregulated fatty acid metabolism holds great promise to uncover novel metabolic vulnerabilities and improve the efficacy of targeted therapies. |
|---|---|
| AbstractList | A common feature of cancer cells is their ability to rewire their metabolism to sustain the production of ATP and macromolecules needed for cell growth, division and survival. In particular, the importance of altered fatty acid metabolism in cancer has received renewed interest as, aside their principal role as structural components of the membrane matrix, they are important secondary messengers, and can also serve as fuel sources for energy production. In this review, we will examine the mechanisms through which cancer cells rewire their fatty acid metabolism with a focus on four main areas of research. (1) The role of de novo synthesis and exogenous uptake in the cellular pool of fatty acids. (2) The mechanisms through which molecular heterogeneity and oncogenic signal transduction pathways, such as PI3K-AKT-mTOR signalling, regulate fatty acid metabolism. (3) The role of fatty acids as essential mediators of cancer progression and metastasis, through remodelling of the tumour microenvironment. (4) Therapeutic strategies and considerations for successfully targeting fatty acid metabolism in cancer. Further research focusing on the complex interplay between oncogenic signalling and dysregulated fatty acid metabolism holds great promise to uncover novel metabolic vulnerabilities and improve the efficacy of targeted therapies.A common feature of cancer cells is their ability to rewire their metabolism to sustain the production of ATP and macromolecules needed for cell growth, division and survival. In particular, the importance of altered fatty acid metabolism in cancer has received renewed interest as, aside their principal role as structural components of the membrane matrix, they are important secondary messengers, and can also serve as fuel sources for energy production. In this review, we will examine the mechanisms through which cancer cells rewire their fatty acid metabolism with a focus on four main areas of research. (1) The role of de novo synthesis and exogenous uptake in the cellular pool of fatty acids. (2) The mechanisms through which molecular heterogeneity and oncogenic signal transduction pathways, such as PI3K-AKT-mTOR signalling, regulate fatty acid metabolism. (3) The role of fatty acids as essential mediators of cancer progression and metastasis, through remodelling of the tumour microenvironment. (4) Therapeutic strategies and considerations for successfully targeting fatty acid metabolism in cancer. Further research focusing on the complex interplay between oncogenic signalling and dysregulated fatty acid metabolism holds great promise to uncover novel metabolic vulnerabilities and improve the efficacy of targeted therapies. A common feature of cancer cells is their ability to rewire their metabolism to sustain the production of ATP and macromolecules needed for cell growth, division and survival. In particular, the importance of altered fatty acid metabolism in cancer has received renewed interest as, aside their principal role as structural components of the membrane matrix, they are important secondary messengers, and can also serve as fuel sources for energy production. In this review, we will examine the mechanisms through which cancer cells rewire their fatty acid metabolism with a focus on four main areas of research. (1) The role of de novo synthesis and exogenous uptake in the cellular pool of fatty acids. (2) The mechanisms through which molecular heterogeneity and oncogenic signal transduction pathways, such as PI3K–AKT–mTOR signalling, regulate fatty acid metabolism. (3) The role of fatty acids as essential mediators of cancer progression and metastasis, through remodelling of the tumour microenvironment. (4) Therapeutic strategies and considerations for successfully targeting fatty acid metabolism in cancer. Further research focusing on the complex interplay between oncogenic signalling and dysregulated fatty acid metabolism holds great promise to uncover novel metabolic vulnerabilities and improve the efficacy of targeted therapies. |
| Author | Koundouros, Nikos Poulogiannis, George |
| Author_xml | – sequence: 1 givenname: Nikos surname: Koundouros fullname: Koundouros, Nikos organization: Signalling and Cancer Metabolism Team, Division of Cancer Biology, The Institute of Cancer Research – sequence: 2 givenname: George surname: Poulogiannis fullname: Poulogiannis, George email: george.poulogiannis@icr.ac.uk organization: Signalling and Cancer Metabolism Team, Division of Cancer Biology, The Institute of Cancer Research, Division of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31819192$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUtrHDEQhEVwiNd2foAvZiCXXCZpPWYkXQzB5AWGQIjPokcjrWVmpLU0G7B_fbSsnYfBOTWivyqqVUfkIKboCDml8I4CV--LoIL2LVDdQt9Be_-CrGjHWUsVkwdkBQCyBc3gkByVclOfGpR8RQ45VVRTzVYEvrtNTuuM8xziukm-8bgsdw3aMDazW3BIUyhzE2JjMVqXT8hLj1Nxrx_mMbn69PHHxZf28tvnrxcfLlvb8X5pR2HdwBwoRUfsGA4jVU7arndMaItDJ6TX0HO06DUqrwfgHDxFaS0IP_Bjcr733WyH2Y3WxSXjZDY5zJjvTMJg_t3EcG3W6afpdS96qarB2weDnG63rixmDsW6acLo0rYYxhkXUtNuh755gt6kbY71vEoJxpViqqvU2d-Jfkd5_MwKyD1gcyolO29sWHAJaRcwTIaC2dVm9rWZWpvZ1Wbuq5I-UT6a_0_D9ppS2bh2-U_o50W_ACsnqpM |
| CitedBy_id | crossref_primary_10_1016_j_fbio_2023_103213 crossref_primary_10_3389_fcell_2023_1254313 crossref_primary_10_3390_metabo13050615 crossref_primary_10_1007_s12079_021_00609_3 crossref_primary_10_1016_j_drudis_2025_104478 crossref_primary_10_1007_s12672_024_01306_4 crossref_primary_10_3389_fonc_2025_1541429 crossref_primary_10_1186_s13062_021_00294_7 crossref_primary_10_1186_s13578_024_01308_3 crossref_primary_10_3389_fonc_2023_1187279 crossref_primary_10_3390_molecules26216541 crossref_primary_10_1186_s12920_022_01256_2 crossref_primary_10_3389_fonc_2022_916375 crossref_primary_10_1016_j_intimp_2021_108427 crossref_primary_10_1016_j_molmet_2024_101930 crossref_primary_10_3389_fphar_2022_837055 crossref_primary_10_1007_s10555_024_10170_1 crossref_primary_10_1089_ars_2023_0262 crossref_primary_10_3390_biomedicines10061284 crossref_primary_10_1210_endocr_bqac041 crossref_primary_10_1038_s41388_023_02788_2 crossref_primary_10_1038_s41540_023_00305_5 crossref_primary_10_37349_ei_2025_1003187 crossref_primary_10_1016_j_jhep_2022_02_003 crossref_primary_10_3389_fonc_2024_1436955 crossref_primary_10_1016_j_canlet_2020_04_016 crossref_primary_10_3389_fmed_2024_1436866 crossref_primary_10_1016_j_bbcan_2023_188962 crossref_primary_10_3390_cancers13020301 crossref_primary_10_3390_ijms24119614 crossref_primary_10_1159_000533156 crossref_primary_10_3390_genes15060755 crossref_primary_10_1186_s12944_021_01599_2 crossref_primary_10_3389_fendo_2023_1248575 crossref_primary_10_1016_j_jff_2021_104570 crossref_primary_10_3390_cancers14153714 crossref_primary_10_1016_j_bbadis_2025_168043 crossref_primary_10_2147_BCTT_S383759 crossref_primary_10_3390_molecules26134100 crossref_primary_10_1038_s42255_023_00786_y crossref_primary_10_1002_cam4_6481 crossref_primary_10_1016_j_ejphar_2023_175497 crossref_primary_10_3390_cancers13081973 crossref_primary_10_1038_s41467_022_32101_w crossref_primary_10_1016_j_phymed_2023_154902 crossref_primary_10_1016_j_ijbiomac_2025_144168 crossref_primary_10_1093_ejendo_lvaf055 crossref_primary_10_1007_s13105_024_01042_x crossref_primary_10_1016_j_tranon_2025_102513 crossref_primary_10_1007_s12032_024_02484_5 crossref_primary_10_1186_s12944_025_02490_0 crossref_primary_10_1016_j_tranon_2024_102056 crossref_primary_10_1158_2159_8290_CD_24_0861 crossref_primary_10_1016_j_cmet_2022_09_023 crossref_primary_10_1016_j_phymed_2025_156612 crossref_primary_10_3390_cancers14184491 crossref_primary_10_3390_cancers13215447 crossref_primary_10_1111_jcmm_18044 crossref_primary_10_1021_cbmi_5c00104 crossref_primary_10_3390_cancers14092222 crossref_primary_10_3390_cancers17142341 crossref_primary_10_1016_j_compbiolchem_2024_108323 crossref_primary_10_3390_metabo13101059 crossref_primary_10_3389_fphar_2021_670167 crossref_primary_10_3390_metabo10090345 crossref_primary_10_1038_s41598_023_28807_6 crossref_primary_10_1016_j_cllc_2022_05_012 crossref_primary_10_1002_cbic_202100628 crossref_primary_10_1007_s13577_023_00915_5 crossref_primary_10_1002_advs_202415181 crossref_primary_10_3390_biomedicines11092401 crossref_primary_10_31083_j_fbl2904143 crossref_primary_10_18632_oncotarget_28750 crossref_primary_10_3892_ijo_2025_5721 crossref_primary_10_1038_s12276_025_01430_3 crossref_primary_10_1016_j_genrep_2025_102157 crossref_primary_10_3390_cancers13030399 crossref_primary_10_1038_s41598_024_81448_1 crossref_primary_10_3389_fonc_2023_1271505 crossref_primary_10_1111_febs_16296 crossref_primary_10_1124_molpharm_122_000607 crossref_primary_10_1038_s41598_024_71439_7 crossref_primary_10_3390_cancers13030393 crossref_primary_10_1177_15330338251331960 crossref_primary_10_3390_metabo12040350 crossref_primary_10_1158_0008_5472_CAN_20_3863 crossref_primary_10_3390_ijms25179303 crossref_primary_10_1016_j_intimp_2024_112319 crossref_primary_10_3389_fonc_2022_850401 crossref_primary_10_3390_ijms23042170 crossref_primary_10_3390_cells12131700 crossref_primary_10_3390_ijms22094384 crossref_primary_10_1016_j_ajpath_2024_07_002 crossref_primary_10_3389_fimmu_2024_1424237 crossref_primary_10_3389_fgene_2022_875894 crossref_primary_10_1016_j_heliyon_2023_e19815 crossref_primary_10_3390_cancers14174245 crossref_primary_10_1002_ejlt_202200128 crossref_primary_10_1016_j_bbalip_2025_159679 crossref_primary_10_1128_aem_02215_21 crossref_primary_10_1155_2023_9328344 crossref_primary_10_1007_s11427_023_2352_9 crossref_primary_10_1016_j_canlet_2022_215815 crossref_primary_10_1007_s12672_024_01642_5 crossref_primary_10_1038_s41598_025_02588_6 crossref_primary_10_3390_cancers12061436 crossref_primary_10_1016_j_cmet_2025_08_008 crossref_primary_10_1007_s00018_023_04902_9 crossref_primary_10_3390_cancers13163957 crossref_primary_10_3390_metabo15080513 crossref_primary_10_3389_fphar_2024_1475102 crossref_primary_10_3892_or_2024_8851 crossref_primary_10_1002_advs_202303570 crossref_primary_10_3389_fonc_2022_1038932 crossref_primary_10_1042_BSR20241235 crossref_primary_10_1093_clinchem_hvac191 crossref_primary_10_7554_eLife_97019 crossref_primary_10_1038_s41368_024_00342_8 crossref_primary_10_3389_fgene_2021_724149 crossref_primary_10_3390_ijms24119601 crossref_primary_10_1007_s12672_024_01069_y crossref_primary_10_1111_cas_70191 crossref_primary_10_3390_metabo13070872 crossref_primary_10_3389_fonc_2022_988626 crossref_primary_10_3390_cancers13153917 crossref_primary_10_3390_cells10113197 crossref_primary_10_3390_cells11142146 crossref_primary_10_1016_j_ecoenv_2023_115513 crossref_primary_10_1016_j_molmet_2024_101966 crossref_primary_10_1007_s11306_023_02076_w crossref_primary_10_1016_j_molmet_2024_101964 crossref_primary_10_3390_cancers14092262 crossref_primary_10_3389_fonc_2024_1453090 crossref_primary_10_1093_jleuko_qiaf072 crossref_primary_10_3390_metabo12070643 crossref_primary_10_3390_metabo12070644 crossref_primary_10_1016_j_freeradbiomed_2024_10_258 crossref_primary_10_3389_fonc_2022_1024789 crossref_primary_10_1016_j_canlet_2020_10_021 crossref_primary_10_1038_s43018_023_00563_6 crossref_primary_10_1186_s12967_024_05084_z crossref_primary_10_3389_fimmu_2024_1456719 crossref_primary_10_1142_S2737416525300019 crossref_primary_10_1155_2022_9569226 crossref_primary_10_1038_s41419_022_05242_5 crossref_primary_10_1016_j_bios_2023_115838 crossref_primary_10_3389_fphar_2024_1514811 crossref_primary_10_5937_arhfarm74_50830 crossref_primary_10_1038_s41389_022_00420_8 crossref_primary_10_3390_cancers12010253 crossref_primary_10_2147_CMAR_S510010 crossref_primary_10_1016_j_phrs_2022_106553 crossref_primary_10_1016_j_chroma_2020_461233 crossref_primary_10_1007_s43152_024_00057_2 crossref_primary_10_1038_s41417_024_00827_y crossref_primary_10_3390_metabo11010028 crossref_primary_10_1016_j_jbc_2024_107214 crossref_primary_10_1038_s41416_021_01479_7 crossref_primary_10_1186_s12885_025_14717_5 crossref_primary_10_3389_fonc_2023_1106667 crossref_primary_10_3390_ijms252111384 crossref_primary_10_1002_cac2_70038 crossref_primary_10_1016_j_ctarc_2025_100953 crossref_primary_10_1016_j_asjsur_2024_01_077 crossref_primary_10_1080_14728222_2025_2532394 crossref_primary_10_1186_s40168_025_02133_7 crossref_primary_10_1097_CM9_0000000000002880 crossref_primary_10_1002_pros_24461 crossref_primary_10_1186_s40170_025_00400_7 crossref_primary_10_32604_or_2023_043138 crossref_primary_10_1186_s12885_024_12519_9 crossref_primary_10_1016_j_chroma_2024_465377 crossref_primary_10_1007_s12026_024_09505_5 crossref_primary_10_1080_2162402X_2021_1965319 crossref_primary_10_1016_j_semcancer_2021_01_001 crossref_primary_10_1186_s13020_024_01050_5 crossref_primary_10_3390_ijms232415831 crossref_primary_10_1016_j_phymed_2024_156165 crossref_primary_10_1038_s41698_024_00647_1 crossref_primary_10_3390_jcm9103191 crossref_primary_10_1158_1541_7786_MCR_24_0747 crossref_primary_10_1038_s41392_020_00361_x crossref_primary_10_3390_cancers13184688 crossref_primary_10_3350_cmh_2024_1039 crossref_primary_10_3390_ijms23094875 crossref_primary_10_3390_cancers17010054 crossref_primary_10_3390_cancers15194796 crossref_primary_10_3389_fimmu_2022_970702 crossref_primary_10_3390_cells10020304 crossref_primary_10_1002_advs_202414232 crossref_primary_10_3390_ijms241512202 crossref_primary_10_1016_j_bbcan_2025_189322 crossref_primary_10_3389_fcell_2020_583850 crossref_primary_10_3390_ijms232415603 crossref_primary_10_1002_jbt_23687 crossref_primary_10_1016_j_cels_2022_11_005 crossref_primary_10_1111_pin_70034 crossref_primary_10_1016_j_heliyon_2024_e38193 crossref_primary_10_22159_ajpcr_2025v18i7_54650 crossref_primary_10_1007_s11306_021_01819_x crossref_primary_10_1038_s42003_023_04730_4 crossref_primary_10_1038_s41419_024_06897_y crossref_primary_10_1016_j_jfca_2021_103808 crossref_primary_10_1177_17588359221079123 crossref_primary_10_3389_fonc_2022_783908 crossref_primary_10_1186_s12967_024_05138_2 crossref_primary_10_3389_fonc_2022_843742 crossref_primary_10_1038_s41467_022_33034_0 crossref_primary_10_1111_odi_14895 crossref_primary_10_3389_fonc_2022_901951 crossref_primary_10_1016_j_bbcan_2024_189258 crossref_primary_10_3390_cancers14194696 crossref_primary_10_3389_fendo_2023_1292011 crossref_primary_10_3390_molecules28083624 crossref_primary_10_1016_j_canlet_2023_216329 crossref_primary_10_1155_2021_5754592 crossref_primary_10_3892_ijo_2024_5680 crossref_primary_10_1016_j_critrevonc_2024_104599 crossref_primary_10_1096_fba_2022_00017 crossref_primary_10_1186_s40170_020_00237_2 crossref_primary_10_1016_j_bioadv_2022_212850 crossref_primary_10_3389_fcell_2022_948097 crossref_primary_10_1016_j_heliyon_2023_e13661 crossref_primary_10_1126_scitranslmed_abq6288 crossref_primary_10_1002_ctm2_1766 crossref_primary_10_1016_j_ab_2025_115852 crossref_primary_10_3390_biology14091151 crossref_primary_10_1111_cas_15515 crossref_primary_10_1007_s12672_024_01402_5 crossref_primary_10_3390_ijms22073661 crossref_primary_10_1038_s41388_022_02551_z crossref_primary_10_1016_j_bbrc_2024_151012 crossref_primary_10_1073_pnas_2402674121 crossref_primary_10_3390_cancers14153763 crossref_primary_10_1038_s41419_021_04262_x crossref_primary_10_1186_s13046_023_02634_z crossref_primary_10_1016_j_devcel_2021_04_019 crossref_primary_10_1038_s41420_024_01823_9 crossref_primary_10_24060_2076_3093_2022_12_2_93_97 crossref_primary_10_1016_j_jpha_2022_08_004 crossref_primary_10_1002_1873_3468_14820 crossref_primary_10_1016_j_bcp_2025_117208 crossref_primary_10_1158_2159_8290_CD_21_0558 crossref_primary_10_1016_j_mgene_2020_100798 crossref_primary_10_1002_jcp_31137 crossref_primary_10_1016_j_devcel_2023_07_005 crossref_primary_10_1038_s42003_025_07451_y crossref_primary_10_1093_nar_gkac1109 crossref_primary_10_1080_00032719_2024_2372670 crossref_primary_10_1038_s41540_025_00506_0 crossref_primary_10_1038_s42003_023_04987_9 crossref_primary_10_3389_fimmu_2022_1090429 crossref_primary_10_1016_j_canlet_2023_216352 crossref_primary_10_1038_s41585_022_00686_y crossref_primary_10_3389_fonc_2021_682911 crossref_primary_10_3389_fimmu_2022_843515 crossref_primary_10_3390_biom12101401 crossref_primary_10_1038_s41420_024_02184_z crossref_primary_10_3389_fphar_2024_1355269 crossref_primary_10_1016_j_ecoenv_2021_112956 crossref_primary_10_1021_acs_jmedchem_5c00535 crossref_primary_10_4102_ajlm_v13i1_2374 crossref_primary_10_1016_j_jare_2025_08_023 crossref_primary_10_3389_fphar_2022_1032806 crossref_primary_10_3390_cancers13225845 crossref_primary_10_1016_j_foodres_2024_114986 crossref_primary_10_3390_antiox12112012 crossref_primary_10_3390_cells10051056 crossref_primary_10_1016_j_bbrc_2020_05_133 crossref_primary_10_1007_s12672_024_01499_8 crossref_primary_10_1186_s12903_023_02859_6 crossref_primary_10_3390_biomedicines9040361 crossref_primary_10_1016_j_trsl_2023_07_001 crossref_primary_10_1186_s12935_021_02108_2 crossref_primary_10_1016_j_ccr_2023_215540 crossref_primary_10_1016_j_semcancer_2021_07_004 crossref_primary_10_3390_molecules27238301 crossref_primary_10_1038_s41420_025_02670_y crossref_primary_10_1111_bph_15424 crossref_primary_10_3390_nu16121905 crossref_primary_10_3389_fimmu_2025_1669822 crossref_primary_10_1002_jbt_70001 crossref_primary_10_3389_fonc_2022_958696 crossref_primary_10_3390_cancers15010259 crossref_primary_10_1093_jmicro_dfac034 crossref_primary_10_1002_VIW_20220086 crossref_primary_10_1186_s12885_024_12842_1 crossref_primary_10_1016_j_pharmthera_2025_108849 crossref_primary_10_1080_07853890_2024_2447403 crossref_primary_10_1038_s41419_022_05540_y crossref_primary_10_1038_s41467_024_46696_9 crossref_primary_10_1186_s43556_025_00300_8 crossref_primary_10_1038_s41392_022_01099_4 crossref_primary_10_1002_cac2_12644 crossref_primary_10_1038_s41467_024_51444_0 crossref_primary_10_1016_j_canlet_2023_216425 crossref_primary_10_3390_biomedicines12010109 crossref_primary_10_3389_fonc_2024_1326970 crossref_primary_10_3390_ijms21030869 crossref_primary_10_1016_j_bbagrm_2021_194724 crossref_primary_10_2174_0115665232308821240826075513 crossref_primary_10_1097_MD_0000000000038347 crossref_primary_10_1098_rsos_220031 crossref_primary_10_1007_s11010_023_04685_4 crossref_primary_10_3390_metabo12060544 crossref_primary_10_1038_s41598_024_62917_z crossref_primary_10_3390_ijms26030889 crossref_primary_10_1093_bjsopen_zrab013 crossref_primary_10_1038_s41388_024_02975_9 crossref_primary_10_3390_cancers14246267 crossref_primary_10_1007_s11306_022_01964_x crossref_primary_10_1016_j_humgen_2024_201313 crossref_primary_10_3389_fimmu_2024_1331641 crossref_primary_10_1016_j_biopha_2023_114477 crossref_primary_10_1038_s41417_024_00846_9 crossref_primary_10_3390_metabo12010080 crossref_primary_10_1007_s00292_024_01368_9 crossref_primary_10_1186_s13046_022_02259_8 crossref_primary_10_3389_fonc_2021_751086 crossref_primary_10_1038_s41540_025_00535_9 crossref_primary_10_1038_s41598_025_06459_y crossref_primary_10_3390_biomedicines11030889 crossref_primary_10_1016_j_imbio_2021_152150 crossref_primary_10_1186_s12920_022_01414_6 crossref_primary_10_3389_fphar_2025_1516583 crossref_primary_10_3390_ijms252011185 crossref_primary_10_1007_s12672_023_00679_2 crossref_primary_10_1016_j_ebiom_2022_104014 crossref_primary_10_1097_CMR_0000000000000722 crossref_primary_10_1038_s41417_022_00521_x crossref_primary_10_1038_s41388_023_02902_4 crossref_primary_10_1002_jcb_30347 crossref_primary_10_1016_j_prostaglandins_2025_106988 crossref_primary_10_3390_ijms21155487 crossref_primary_10_1016_j_cellsig_2024_111087 crossref_primary_10_1186_s13019_024_03199_4 crossref_primary_10_3389_fonc_2022_916850 crossref_primary_10_1038_s41598_023_45560_y crossref_primary_10_3390_metabo14010042 crossref_primary_10_1016_j_bbcan_2021_188655 crossref_primary_10_3892_ijo_2024_5713 crossref_primary_10_1038_s41467_022_30309_4 crossref_primary_10_3390_metabo13111108 crossref_primary_10_4103_RPS_RPS_209_23 crossref_primary_10_1007_s00432_022_04501_4 crossref_primary_10_3390_cancers14143449 crossref_primary_10_1080_14728222_2023_2255377 crossref_primary_10_1084_jem_20241102 crossref_primary_10_1186_s40164_025_00689_6 crossref_primary_10_3390_cancers13123065 crossref_primary_10_1007_s10479_024_06433_3 crossref_primary_10_1186_s12943_024_01962_8 crossref_primary_10_1186_s12964_025_02363_0 crossref_primary_10_3390_cancers13143417 crossref_primary_10_1186_s40170_021_00266_5 crossref_primary_10_3390_ijms231911745 crossref_primary_10_1186_s41065_025_00425_4 crossref_primary_10_3389_fonc_2023_1165862 crossref_primary_10_3390_ijms24044219 crossref_primary_10_1016_j_ijbiomac_2025_142414 crossref_primary_10_1038_s41598_023_49010_7 crossref_primary_10_1016_j_semcancer_2024_06_003 crossref_primary_10_1038_s41388_024_03228_5 crossref_primary_10_1016_j_tranon_2024_101952 crossref_primary_10_3390_cells11071157 crossref_primary_10_1038_s41467_025_56458_w crossref_primary_10_3390_ijms23020604 crossref_primary_10_1038_s42003_022_03788_w crossref_primary_10_3389_fimmu_2022_1050721 crossref_primary_10_3390_cancers14194663 crossref_primary_10_1007_s00740_025_00548_4 crossref_primary_10_1016_j_celrep_2024_114516 crossref_primary_10_1016_j_heliyon_2023_e22768 crossref_primary_10_1038_s41588_024_01969_3 crossref_primary_10_3389_fonc_2021_745209 crossref_primary_10_1007_s00262_023_03603_3 crossref_primary_10_1038_s41420_025_02354_7 crossref_primary_10_1159_000516488 crossref_primary_10_1186_s13578_025_01388_9 crossref_primary_10_3389_fonc_2020_580617 crossref_primary_10_1038_s41598_022_21483_y crossref_primary_10_1038_s41420_024_02126_9 crossref_primary_10_3390_cancers16173028 crossref_primary_10_3389_fendo_2023_1126271 crossref_primary_10_1002_jcb_30574 crossref_primary_10_3389_fcell_2025_1664292 crossref_primary_10_1186_s12964_023_01417_5 crossref_primary_10_1016_j_critrevonc_2025_104910 crossref_primary_10_1016_j_heliyon_2024_e28120 crossref_primary_10_1016_j_semcancer_2022_02_004 crossref_primary_10_3390_metabo12010036 crossref_primary_10_3390_biomedicines11051365 crossref_primary_10_1007_s00262_023_03577_2 crossref_primary_10_1007_s00232_024_00328_x crossref_primary_10_3390_antiox12071329 crossref_primary_10_1016_j_chemphyslip_2022_105269 crossref_primary_10_1038_s41388_024_03132_y crossref_primary_10_1186_s40170_025_00385_3 crossref_primary_10_1177_15347354251331100 crossref_primary_10_1038_s41467_022_30153_6 crossref_primary_10_3390_metabo12040315 crossref_primary_10_1038_s41589_025_01998_x crossref_primary_10_1016_j_cancergen_2021_11_001 crossref_primary_10_3389_fendo_2022_988295 crossref_primary_10_3389_fonc_2023_1102518 crossref_primary_10_3390_ijms24098441 crossref_primary_10_3390_life12060784 crossref_primary_10_3390_cancers14082041 crossref_primary_10_1111_febs_70193 crossref_primary_10_1080_2162402X_2022_2147317 crossref_primary_10_1016_j_tranon_2024_101902 crossref_primary_10_3390_cancers14082040 crossref_primary_10_1002_med_22010 crossref_primary_10_1242_dmm_044420 crossref_primary_10_1155_2021_8842105 crossref_primary_10_1186_s43046_025_00317_8 crossref_primary_10_1158_0008_5472_CAN_23_0969 crossref_primary_10_1002_jcb_30155 crossref_primary_10_3389_fendo_2024_1460278 crossref_primary_10_1038_s41392_021_00714_0 crossref_primary_10_1128_mbio_03954_24 crossref_primary_10_1073_pnas_2319254121 crossref_primary_10_1039_D5QI00168D crossref_primary_10_3390_nu16172884 crossref_primary_10_1007_s11306_023_02024_8 crossref_primary_10_3390_ijms23052480 crossref_primary_10_3389_fimmu_2022_768606 crossref_primary_10_1007_s12282_022_01356_y crossref_primary_10_1080_15384047_2024_2325130 crossref_primary_10_1111_jcmm_70710 crossref_primary_10_1016_j_ejphar_2023_175655 crossref_primary_10_3892_ol_2024_14294 crossref_primary_10_3390_cells12060860 crossref_primary_10_1007_s10555_021_09996_w crossref_primary_10_1016_j_bcp_2024_116721 crossref_primary_10_1038_s41598_025_97641_9 crossref_primary_10_1073_pnas_2408049121 crossref_primary_10_1016_j_canlet_2020_06_013 crossref_primary_10_3389_fphar_2024_1516650 crossref_primary_10_3389_fgene_2022_790690 crossref_primary_10_3389_fendo_2022_950345 crossref_primary_10_1002_eji_202048944 crossref_primary_10_1038_s41467_024_54621_3 crossref_primary_10_1016_j_molcel_2021_08_027 crossref_primary_10_1016_j_molcel_2021_08_026 crossref_primary_10_3390_biom12050706 crossref_primary_10_1186_s13052_025_01921_z crossref_primary_10_3390_biom12050702 crossref_primary_10_1021_acscentsci_3c00286 crossref_primary_10_1016_j_tem_2024_02_008 crossref_primary_10_1002_advs_202307963 crossref_primary_10_1016_j_bbih_2025_101061 crossref_primary_10_3390_cancers12113469 crossref_primary_10_1186_s12957_023_03223_2 crossref_primary_10_1007_s00394_021_02488_1 crossref_primary_10_1016_j_canlet_2020_06_024 crossref_primary_10_3390_metabo14070383 crossref_primary_10_3389_fimmu_2022_916284 crossref_primary_10_1016_j_tibtech_2025_06_002 crossref_primary_10_3390_membranes11120919 crossref_primary_10_1097_MEG_0000000000001842 crossref_primary_10_1038_s41598_025_05480_5 crossref_primary_10_1371_journal_ppat_1012685 crossref_primary_10_1093_toxsci_kfae012 crossref_primary_10_3390_cancers15020411 crossref_primary_10_3390_molecules29020531 crossref_primary_10_3389_fmicb_2022_919496 crossref_primary_10_1016_j_tranon_2024_102197 crossref_primary_10_3389_fonc_2025_1570873 crossref_primary_10_2217_fon_2020_0399 crossref_primary_10_1016_j_jlr_2024_100721 crossref_primary_10_1002_mc_23379 crossref_primary_10_1186_s12967_025_06698_7 crossref_primary_10_1002_mnfr_70092 crossref_primary_10_29219_fnr_v68_10434 crossref_primary_10_5306_wjco_v15_i1_130 crossref_primary_10_1038_s41467_024_45782_2 crossref_primary_10_1002_mc_23383 crossref_primary_10_3390_ijms232113128 crossref_primary_10_1016_j_bbcan_2025_189292 crossref_primary_10_1002_mco2_70387 crossref_primary_10_3390_ijms26125670 crossref_primary_10_1016_j_critrevonc_2022_103796 crossref_primary_10_1007_s10555_021_10006_2 crossref_primary_10_1007_s12094_022_03066_5 crossref_primary_10_1016_j_bbrc_2023_06_044 crossref_primary_10_3390_metabo13040508 crossref_primary_10_3389_fonc_2022_835626 crossref_primary_10_1002_jrs_6279 crossref_primary_10_1038_s41467_022_35511_y crossref_primary_10_1186_s12935_022_02621_y crossref_primary_10_1186_s13045_023_01498_2 crossref_primary_10_3389_fonc_2025_1579423 crossref_primary_10_1016_j_biopha_2022_113032 crossref_primary_10_1016_j_tips_2023_12_005 crossref_primary_10_1007_s11033_020_05352_3 crossref_primary_10_1038_s43018_023_00702_z crossref_primary_10_5306_wjco_v15_i1_45 crossref_primary_10_3389_fonc_2023_1122789 crossref_primary_10_3389_fonc_2024_1442911 crossref_primary_10_1007_s12291_023_01140_5 crossref_primary_10_1002_1878_0261_13424 crossref_primary_10_1038_s41467_023_35796_7 crossref_primary_10_1038_s41467_022_33138_7 crossref_primary_10_1096_fj_202101333R crossref_primary_10_1186_s12935_024_03416_z crossref_primary_10_3390_cancers15133451 crossref_primary_10_1016_j_yexcr_2025_114727 crossref_primary_10_4155_fmc_2021_0341 crossref_primary_10_3389_fonc_2023_1168996 crossref_primary_10_1016_j_plipres_2021_101143 crossref_primary_10_1007_s10495_022_01795_0 crossref_primary_10_1007_s12020_024_03993_z crossref_primary_10_1007_s11060_022_04189_z crossref_primary_10_1177_00368504251352375 crossref_primary_10_3390_cancers12102780 crossref_primary_10_3390_metabo14060309 crossref_primary_10_1002_gcc_70008 crossref_primary_10_3390_ijms22168844 crossref_primary_10_3390_antiox13020220 crossref_primary_10_3390_life13040996 crossref_primary_10_1016_j_tranon_2021_101218 crossref_primary_10_3389_fonc_2021_703681 crossref_primary_10_3390_ijms231810587 crossref_primary_10_1111_cas_15454 crossref_primary_10_3390_biomedicines11020280 crossref_primary_10_1007_s11306_024_02096_0 crossref_primary_10_1007_s12672_025_02135_9 crossref_primary_10_3390_pharmaceutics14061303 crossref_primary_10_3389_fphar_2020_01202 crossref_primary_10_61958_NCPT2557 crossref_primary_10_1002_1878_0261_13525 crossref_primary_10_3389_fcell_2025_1615454 crossref_primary_10_1080_00207454_2024_2353367 crossref_primary_10_1080_14737159_2023_2195553 crossref_primary_10_1016_j_cell_2025_07_041 crossref_primary_10_1038_s41420_024_01933_4 crossref_primary_10_1186_s12964_024_01792_7 crossref_primary_10_1038_s41598_025_04886_5 crossref_primary_10_1007_s11259_022_09975_8 crossref_primary_10_1016_j_semcancer_2025_03_003 crossref_primary_10_1186_s12937_025_01135_3 crossref_primary_10_1016_j_bbrc_2023_06_090 crossref_primary_10_1016_j_yexcr_2025_114508 crossref_primary_10_1002_ctm2_1045 crossref_primary_10_1016_j_tranon_2021_101207 crossref_primary_10_1016_j_canlet_2025_217750 crossref_primary_10_1111_cas_15445 crossref_primary_10_1038_s43018_023_00653_5 crossref_primary_10_1016_j_bioactmat_2023_12_021 crossref_primary_10_1186_s12866_022_02458_5 crossref_primary_10_3390_cells11020225 crossref_primary_10_3390_metabo15020136 crossref_primary_10_25259_Cytojournal_68_2023 crossref_primary_10_1016_j_genrep_2020_100992 crossref_primary_10_3390_metabo12030213 crossref_primary_10_1007_s42764_022_00078_x crossref_primary_10_1007_s10911_021_09505_3 crossref_primary_10_3390_ijms25031643 crossref_primary_10_1080_15384047_2023_2176692 crossref_primary_10_1002_iub_70048 crossref_primary_10_1016_j_intimp_2024_113702 crossref_primary_10_1016_j_jff_2024_106223 crossref_primary_10_1038_s41565_024_01690_6 crossref_primary_10_1128_msystems_00276_25 crossref_primary_10_1038_s42003_024_06993_x crossref_primary_10_1158_0008_5472_CAN_23_1641 crossref_primary_10_3390_ijms23115972 crossref_primary_10_7717_peerj_17749 crossref_primary_10_1016_j_canlet_2024_217426 crossref_primary_10_3389_fonc_2022_986367 crossref_primary_10_1038_s41416_024_02637_3 crossref_primary_10_3390_biom15060820 crossref_primary_10_1155_2022_2339584 crossref_primary_10_1158_0008_5472_CAN_21_4044 crossref_primary_10_1186_s12944_024_02025_z crossref_primary_10_3390_cancers14092340 crossref_primary_10_3390_cancers17121942 crossref_primary_10_1016_j_clnu_2021_12_033 crossref_primary_10_1038_s41598_020_70839_9 crossref_primary_10_1007_s40005_024_00689_4 crossref_primary_10_1038_s41598_021_99746_3 crossref_primary_10_3390_biom12111590 crossref_primary_10_1016_j_critrevonc_2021_103545 crossref_primary_10_1016_j_drudis_2025_104397 crossref_primary_10_3390_cancers15194857 crossref_primary_10_1186_s40478_025_02025_9 crossref_primary_10_3389_fendo_2020_00555 crossref_primary_10_1016_j_jpha_2023_08_019 crossref_primary_10_1111_jcmm_70726 crossref_primary_10_1134_S0006350924701161 crossref_primary_10_3390_vetsci9020094 crossref_primary_10_1016_j_envint_2022_107081 crossref_primary_10_3390_cancers13246231 crossref_primary_10_1016_j_mehy_2024_111479 crossref_primary_10_1038_s41571_021_00552_7 crossref_primary_10_1155_2023_6851036 crossref_primary_10_3390_cells11162516 crossref_primary_10_3390_ijms241813928 crossref_primary_10_1016_j_envpol_2021_118680 crossref_primary_10_1155_2023_4556586 crossref_primary_10_1186_s12885_023_10816_3 crossref_primary_10_1016_j_semcancer_2025_02_001 crossref_primary_10_3892_or_2025_8952 crossref_primary_10_1016_j_ajpath_2023_06_014 crossref_primary_10_1111_febs_70081 crossref_primary_10_3389_fgene_2023_1161791 crossref_primary_10_3390_cancers12082252 crossref_primary_10_1073_pnas_2416412122 crossref_primary_10_3390_cells12071007 crossref_primary_10_1186_s12964_024_01913_2 crossref_primary_10_1186_s40364_024_00622_9 crossref_primary_10_1080_09553002_2020_1721597 crossref_primary_10_1186_s13046_021_02223_y crossref_primary_10_3389_fonc_2021_761107 crossref_primary_10_1016_j_abb_2022_109470 crossref_primary_10_3390_ijms24021391 crossref_primary_10_1002_jms_4880 crossref_primary_10_1016_j_bcp_2024_116128 crossref_primary_10_3389_fimmu_2024_1302587 crossref_primary_10_3389_fonc_2022_942798 crossref_primary_10_3390_biomedicines12030541 crossref_primary_10_1016_j_bcp_2024_116122 crossref_primary_10_3389_fonc_2022_999643 crossref_primary_10_1016_j_isci_2023_108081 crossref_primary_10_1038_s41598_024_55458_y crossref_primary_10_1016_j_celrep_2025_115357 crossref_primary_10_1016_j_ejmech_2021_113920 crossref_primary_10_1016_j_tice_2025_103061 crossref_primary_10_1515_chem_2023_0118 crossref_primary_10_3389_fimmu_2023_1021678 crossref_primary_10_1016_j_sjbs_2022_103340 crossref_primary_10_1038_s41419_021_04411_2 crossref_primary_10_1186_s43556_024_00181_3 crossref_primary_10_1002_cam4_4395 crossref_primary_10_3389_fmolb_2023_1206074 crossref_primary_10_3390_ijms24010012 crossref_primary_10_3390_cells9092028 crossref_primary_10_3390_cancers16071313 crossref_primary_10_5812_jjnpp_135038 crossref_primary_10_3390_cancers15143653 crossref_primary_10_1080_15384101_2021_1912889 crossref_primary_10_1007_s12272_021_01352_4 crossref_primary_10_3390_ijms242216057 crossref_primary_10_3390_ijerph191610261 crossref_primary_10_3389_fonc_2021_636917 crossref_primary_10_1016_j_saa_2025_126275 crossref_primary_10_1158_0008_5472_CAN_21_0052 crossref_primary_10_1007_s11033_021_07094_2 crossref_primary_10_1002_JLB_1A0521_251R crossref_primary_10_1111_imr_13316 crossref_primary_10_3389_fgene_2023_1002157 crossref_primary_10_3389_fonc_2021_666320 crossref_primary_10_1186_s40364_024_00681_y crossref_primary_10_3389_fcell_2022_1007641 crossref_primary_10_1016_j_bbcan_2025_189428 crossref_primary_10_1038_s42003_021_02710_0 crossref_primary_10_3390_cells11203182 crossref_primary_10_1016_j_lfs_2024_123167 crossref_primary_10_1158_0008_5472_CAN_21_1392 crossref_primary_10_1002_ctm2_1443 crossref_primary_10_1016_j_bbrc_2022_01_128 crossref_primary_10_1007_s13205_022_03415_9 crossref_primary_10_1080_07391102_2023_2167121 crossref_primary_10_1080_21505594_2024_2395833 crossref_primary_10_1172_JCI157302 crossref_primary_10_3389_fmed_2021_751277 crossref_primary_10_1016_j_yexcr_2024_114055 crossref_primary_10_1038_s41585_022_00654_6 crossref_primary_10_1158_2159_8290_CD_24_1409 crossref_primary_10_1158_1078_0432_CCR_20_0572 crossref_primary_10_1038_s41598_022_08082_7 crossref_primary_10_3389_fmed_2023_1193133 crossref_primary_10_3390_cancers14010228 crossref_primary_10_1016_j_molcel_2023_07_017 crossref_primary_10_1002_cac2_12247 crossref_primary_10_1016_j_envint_2022_107423 crossref_primary_10_1016_j_canlet_2021_03_007 crossref_primary_10_1016_j_jff_2021_104857 crossref_primary_10_1016_j_genrep_2025_102259 crossref_primary_10_1186_s13046_024_03141_5 crossref_primary_10_1016_j_semcancer_2025_02_013 crossref_primary_10_3390_foods11040605 crossref_primary_10_1002_bies_202000052 crossref_primary_10_3390_biomedicines13061299 crossref_primary_10_1016_j_molmet_2021_101389 crossref_primary_10_3390_biom15050626 crossref_primary_10_1002_advs_202501774 crossref_primary_10_3389_fcell_2024_1399065 crossref_primary_10_1038_s41388_023_02593_x crossref_primary_10_1038_s42255_024_01118_4 crossref_primary_10_1186_s13045_022_01340_1 crossref_primary_10_1016_j_seminoncol_2025_152392 crossref_primary_10_1016_j_plipres_2024_101288 crossref_primary_10_3389_fonc_2024_1360471 crossref_primary_10_3390_ijms222413437 crossref_primary_10_1002_jev2_12419 crossref_primary_10_1007_s12672_025_02484_5 crossref_primary_10_1016_j_cnd_2020_09_003 crossref_primary_10_1016_j_taap_2024_117042 crossref_primary_10_3390_pharmaceutics13101629 crossref_primary_10_1016_j_phymed_2024_156023 crossref_primary_10_1016_j_bbcan_2023_189062 crossref_primary_10_1016_j_abb_2025_110472 crossref_primary_10_1073_pnas_2117013119 crossref_primary_10_1186_s13048_024_01389_1 crossref_primary_10_1186_s12943_024_01981_5 crossref_primary_10_3390_biomedicines10020277 crossref_primary_10_1007_s12672_024_01195_7 crossref_primary_10_3390_cancers14122920 crossref_primary_10_1038_s44303_025_00077_z crossref_primary_10_1007_s11306_025_02221_7 crossref_primary_10_1097_HCO_0000000000001118 crossref_primary_10_1016_j_semcancer_2022_10_001 crossref_primary_10_1002_btpr_70002 crossref_primary_10_1080_14728222_2022_2077189 crossref_primary_10_3389_fimmu_2022_955476 crossref_primary_10_1007_s13402_024_00953_7 crossref_primary_10_1371_journal_pcbi_1009228 crossref_primary_10_3892_ijo_2022_5383 crossref_primary_10_1038_s41598_021_00802_9 crossref_primary_10_1016_j_isci_2024_110606 crossref_primary_10_1007_s00232_024_00320_5 crossref_primary_10_1002_adma_202415550 crossref_primary_10_1016_j_semcancer_2022_10_005 crossref_primary_10_1177_11769351221086441 crossref_primary_10_3390_ijms26072843 crossref_primary_10_1038_s41598_024_80921_1 crossref_primary_10_3389_fbioe_2021_694218 crossref_primary_10_3389_fonc_2023_1034205 crossref_primary_10_4014_jmb_2407_07039 crossref_primary_10_3389_fonc_2022_1008361 crossref_primary_10_3390_nu14040851 crossref_primary_10_3390_cancers13071641 crossref_primary_10_1016_j_jbior_2022_100935 crossref_primary_10_1016_j_pharmthera_2023_108519 crossref_primary_10_1021_acs_analchem_5c02999 crossref_primary_10_1002_mef2_59 crossref_primary_10_3390_biomedicines11123186 crossref_primary_10_1016_j_jbc_2024_107351 crossref_primary_10_1038_s44321_024_00090_6 crossref_primary_10_1016_j_canlet_2021_04_023 crossref_primary_10_1016_j_wneu_2025_123723 crossref_primary_10_1038_s41416_023_02237_7 crossref_primary_10_3389_fgene_2022_990153 crossref_primary_10_1021_jasms_3c00181 crossref_primary_10_3390_metabo13020213 crossref_primary_10_3389_fonc_2022_987499 crossref_primary_10_3892_ijo_2022_5399 crossref_primary_10_1111_jvh_13769 crossref_primary_10_1186_s11658_024_00629_y crossref_primary_10_1038_s41420_025_02554_1 crossref_primary_10_1016_j_ajpath_2023_08_005 crossref_primary_10_1016_j_cbi_2021_109370 crossref_primary_10_1186_s41936_024_00406_5 crossref_primary_10_1007_s10585_021_10140_9 crossref_primary_10_3389_fcell_2021_747863 crossref_primary_10_1038_s41467_024_54400_0 crossref_primary_10_1002_hon_3279 crossref_primary_10_1016_j_cytogfr_2023_05_001 crossref_primary_10_1186_s13059_025_03474_0 crossref_primary_10_1038_s41420_025_02409_9 crossref_primary_10_1126_scitranslmed_adm9488 crossref_primary_10_3389_fonc_2022_870721 crossref_primary_10_1186_s13062_022_00319_9 crossref_primary_10_3390_cancers14112629 crossref_primary_10_1007_s00018_025_05617_9 crossref_primary_10_2147_JMDH_S495330 crossref_primary_10_3389_fonc_2023_1217212 crossref_primary_10_1038_s41375_025_02645_z crossref_primary_10_3390_biomedicines13030707 crossref_primary_10_3390_cancers12102890 crossref_primary_10_3390_ijms26178466 crossref_primary_10_3389_fimmu_2025_1529756 crossref_primary_10_1016_j_semcancer_2023_03_001 crossref_primary_10_1016_j_jlr_2022_100223 crossref_primary_10_1016_j_lfs_2024_123322 crossref_primary_10_3389_fonc_2022_1040034 crossref_primary_10_1016_j_xinn_2025_100918 crossref_primary_10_1016_j_isci_2025_112681 crossref_primary_10_3390_biomedicines9111639 crossref_primary_10_3390_metabo10060252 crossref_primary_10_1210_endrev_bnae030 crossref_primary_10_1007_s10549_025_07672_z crossref_primary_10_1016_j_bbcan_2023_189012 crossref_primary_10_1155_2023_2397728 crossref_primary_10_3892_ol_2024_14781 crossref_primary_10_1016_j_lfs_2021_119579 crossref_primary_10_1016_j_cellimm_2022_104639 crossref_primary_10_1530_EC_22_0020 crossref_primary_10_1016_j_heliyon_2023_e16156 crossref_primary_10_3390_cells11050771 crossref_primary_10_3389_fendo_2025_1534393 crossref_primary_10_3390_ijms23116030 crossref_primary_10_1177_11795549241287058 crossref_primary_10_1016_j_ejphar_2022_175456 crossref_primary_10_3390_nu12123832 crossref_primary_10_3390_metabo15040221 crossref_primary_10_1158_1078_0432_CCR_23_3433 crossref_primary_10_1016_j_freeradbiomed_2021_09_024 crossref_primary_10_1186_s12943_024_02119_3 crossref_primary_10_1007_s13659_025_00540_9 crossref_primary_10_1016_j_jncc_2025_02_007 crossref_primary_10_1021_acsptsci_5c00170 crossref_primary_10_1186_s43556_020_00012_1 crossref_primary_10_3390_ijms23179985 crossref_primary_10_1038_s41388_021_02069_w crossref_primary_10_1016_j_bmc_2024_117671 crossref_primary_10_7717_peerj_14622 crossref_primary_10_3390_cancers13040762 crossref_primary_10_1016_j_plipres_2022_101181 crossref_primary_10_3390_cancers14225638 crossref_primary_10_1007_s10528_022_10218_3 crossref_primary_10_1002_jbt_23572 crossref_primary_10_1186_s13045_022_01349_6 crossref_primary_10_3390_ijms221910268 crossref_primary_10_1002_bies_202000205 crossref_primary_10_3390_biom11030364 crossref_primary_10_1038_s41540_025_00525_x crossref_primary_10_1097_GH9_0000000000000512 crossref_primary_10_1002_med_21868 crossref_primary_10_1016_j_cell_2023_07_013 crossref_primary_10_3390_ijms25084559 crossref_primary_10_3390_ijms23095266 crossref_primary_10_3389_fonc_2021_653621 crossref_primary_10_3389_fonc_2023_1251561 crossref_primary_10_3389_fonc_2022_1072806 crossref_primary_10_3389_fphar_2022_949745 crossref_primary_10_3390_biom15081088 crossref_primary_10_1002_jcla_24189 crossref_primary_10_1016_j_tice_2025_102752 crossref_primary_10_1038_s42255_023_00963_z crossref_primary_10_3389_fonc_2024_1328606 crossref_primary_10_1016_j_cca_2021_11_024 crossref_primary_10_3390_cancers14143313 crossref_primary_10_1007_s40291_025_00796_4 crossref_primary_10_1007_s12672_025_01745_7 crossref_primary_10_3389_fcell_2020_581863 crossref_primary_10_1007_s00216_024_05656_4 crossref_primary_10_1007_s10142_023_01158_1 crossref_primary_10_1038_s41375_022_01635_9 crossref_primary_10_3390_cancers14041043 crossref_primary_10_1016_j_talanta_2024_126378 crossref_primary_10_3389_fimmu_2023_1099459 crossref_primary_10_3390_cells11192973 crossref_primary_10_1016_j_cej_2025_163555 crossref_primary_10_1016_j_cmet_2020_10_012 crossref_primary_10_1080_10715762_2020_1726343 crossref_primary_10_3390_ijms25158024 crossref_primary_10_1002_mco2_363 crossref_primary_10_1007_s11912_022_01223_1 crossref_primary_10_1016_j_bbcan_2022_188837 crossref_primary_10_1038_s41598_024_80550_8 crossref_primary_10_1038_s41598_025_13309_4 crossref_primary_10_3389_fonc_2020_578418 crossref_primary_10_1038_s41598_023_43982_2 crossref_primary_10_1155_2021_7483865 crossref_primary_10_1016_j_semcancer_2025_07_006 crossref_primary_10_1016_j_jbc_2024_108042 crossref_primary_10_3389_fmolb_2023_1235160 crossref_primary_10_1016_j_heliyon_2024_e27156 crossref_primary_10_3390_jcm11175096 crossref_primary_10_3390_ijms23105572 crossref_primary_10_3390_ijms26125521 crossref_primary_10_1016_j_pharmthera_2022_108298 crossref_primary_10_3390_biom15030366 crossref_primary_10_1007_s00277_024_06032_z crossref_primary_10_1016_j_lfs_2024_122642 crossref_primary_10_1016_j_neo_2025_101143 crossref_primary_10_1016_j_psj_2025_105314 crossref_primary_10_1016_j_bcp_2025_117192 crossref_primary_10_3390_cells12182240 crossref_primary_10_1016_j_ab_2021_114430 crossref_primary_10_3390_ijms241914543 crossref_primary_10_1016_j_semcancer_2022_07_005 crossref_primary_10_3389_fonc_2022_914594 crossref_primary_10_1016_j_bcp_2023_115697 crossref_primary_10_1007_s12672_025_02613_0 crossref_primary_10_1007_s11306_024_02142_x crossref_primary_10_1038_s42003_023_04924_w crossref_primary_10_1016_j_celrep_2024_114445 crossref_primary_10_3389_fonc_2024_1382986 crossref_primary_10_1016_j_bbcan_2021_188559 crossref_primary_10_20900_immunometab20210003 crossref_primary_10_1016_j_celrep_2025_115804 crossref_primary_10_1186_s13058_025_01991_1 crossref_primary_10_1007_s12010_025_05237_w crossref_primary_10_1007_s00210_025_04553_6 crossref_primary_10_3389_fphar_2022_948610 crossref_primary_10_1016_j_expneurol_2022_114268 crossref_primary_10_1186_s10020_024_00988_4 crossref_primary_10_3390_cancers12051232 crossref_primary_10_1016_j_isci_2025_111758 crossref_primary_10_1016_j_abb_2020_108659 crossref_primary_10_3389_fcell_2022_829029 crossref_primary_10_1016_j_gendis_2025_101772 crossref_primary_10_4251_wjgo_v17_i1_98409 crossref_primary_10_1007_s10528_025_11070_x crossref_primary_10_1016_j_bbadis_2025_167919 crossref_primary_10_1186_s12935_024_03611_y crossref_primary_10_1007_s11548_024_03106_1 crossref_primary_10_1038_s41419_024_06956_4 crossref_primary_10_1093_bib_bbad282 crossref_primary_10_3389_fonc_2023_1116806 crossref_primary_10_1111_1541_4337_12706 crossref_primary_10_3390_biomedicines11082329 crossref_primary_10_1371_journal_pcbi_1009841 crossref_primary_10_1002_2211_5463_13559 crossref_primary_10_2147_IJGM_S337615 crossref_primary_10_1186_s40170_025_00407_0 crossref_primary_10_3389_fcell_2025_1568634 crossref_primary_10_1002_pmic_202300021 crossref_primary_10_1097_MOL_0000000000000788 crossref_primary_10_1186_s12935_025_03656_7 crossref_primary_10_3390_ph13100292 crossref_primary_10_1016_j_addr_2020_07_013 crossref_primary_10_1158_1078_0432_CCR_24_2000 crossref_primary_10_7554_eLife_97019_3 crossref_primary_10_1016_j_cmet_2022_11_003 crossref_primary_10_1038_s41698_025_00977_8 crossref_primary_10_1177_15330338221140655 crossref_primary_10_1007_s00432_023_05580_7 crossref_primary_10_3389_fcell_2022_857919 crossref_primary_10_1002_bmc_5190 crossref_primary_10_1093_jnci_djaf137 crossref_primary_10_1007_s11033_024_10139_x crossref_primary_10_1038_s41556_023_01198_6 crossref_primary_10_1038_s41420_022_01241_9 crossref_primary_10_1002_ijc_35380 crossref_primary_10_1016_j_it_2025_08_005 crossref_primary_10_1002_1878_0261_13582 crossref_primary_10_1038_s41556_022_01002_x crossref_primary_10_1186_s12860_021_00371_9 crossref_primary_10_1016_j_dld_2024_11_008 crossref_primary_10_1021_jacs_1c05103 crossref_primary_10_1177_03936155221123343 crossref_primary_10_3389_fonc_2023_1111778 crossref_primary_10_1186_s40170_024_00367_x crossref_primary_10_1038_s41419_024_06930_0 crossref_primary_10_1038_s41568_022_00537_3 crossref_primary_10_1007_s13577_024_01139_x crossref_primary_10_3390_ijms22042142 crossref_primary_10_1186_s12935_024_03261_0 crossref_primary_10_1016_j_bbalip_2025_159609 crossref_primary_10_1016_j_ejphar_2022_175481 crossref_primary_10_3389_fonc_2023_1218735 crossref_primary_10_3390_cancers14194943 crossref_primary_10_1016_j_gene_2022_146330 crossref_primary_10_1158_1078_0432_CCR_23_2934 crossref_primary_10_4252_wjsc_v13_i9_1307 crossref_primary_10_3389_fonc_2020_604143 crossref_primary_10_3390_ijms24129921 crossref_primary_10_1080_1061186X_2024_2399181 crossref_primary_10_3390_ijms26189132 crossref_primary_10_3390_metabo11110765 crossref_primary_10_3390_cancers13215484 crossref_primary_10_3390_cells14020080 crossref_primary_10_1016_j_toxrep_2024_101884 crossref_primary_10_3390_cancers15154013 crossref_primary_10_1016_j_cis_2023_103011 crossref_primary_10_3389_fonc_2022_1005659 crossref_primary_10_1021_jacs_3c02043 crossref_primary_10_47248_chp2502020006 crossref_primary_10_1016_j_ijbiomac_2021_09_188 crossref_primary_10_1084_jem_20201606 crossref_primary_10_1016_j_ejmech_2022_114233 crossref_primary_10_3389_fimmu_2025_1603032 crossref_primary_10_1002_advs_202507951 crossref_primary_10_1134_S0026893324700729 crossref_primary_10_1016_j_tem_2021_11_002 crossref_primary_10_1016_j_tranon_2023_101700 crossref_primary_10_1007_s12094_023_03282_7 crossref_primary_10_1038_s41417_023_00639_6 crossref_primary_10_3390_metabo15070458 crossref_primary_10_1016_j_jafr_2025_101819 crossref_primary_10_3390_cells14120859 crossref_primary_10_1186_s12943_025_02258_1 crossref_primary_10_3389_fonc_2022_1003222 |
| Cites_doi | 10.1194/jlr.M012195 10.1074/jbc.M111.314112 10.1038/s41586-019-1094-6 10.1152/ajpcell.00266.2015 10.1016/j.biocel.2012.08.022 10.1016/j.ccell.2016.06.004 10.1083/jcb.151.3.483 10.1016/j.ccell.2017.11.011 10.1016/S0022-2275(20)32566-9 10.1126/science.aad0489 10.1074/jbc.M115.660498 10.1016/j.ccr.2009.04.012 10.1016/S0092-8674(05)80095-9 10.1038/nature20791 10.1038/nm.4055 10.1016/j.jhep.2017.06.015 10.1016/j.mam.2008.05.005 10.1016/j.cell.2017.10.037 10.1158/2159-8290.CD-18-0567 10.18632/oncotarget.6696 10.1038/72294 10.1038/nrc.2016.82 10.1158/1535-7163.MCT-07-0445 10.1016/j.trecan.2018.03.004 10.1016/j.bbalip.2014.12.011 10.1038/nm0302-289 10.1074/jbc.M200732200 10.1038/ncomms5244 10.1001/jama.280.18.1596 10.1073/pnas.201524598 10.1038/s41586-019-0904-1 10.1016/j.cell.2016.02.035 10.1038/ncb1534 10.1016/j.cell.2017.07.029 10.1016/j.pharmthera.2017.02.021 10.1016/j.cancergen.2015.03.008 10.1038/nature25465 10.2174/1574888X11666151203223512 10.18632/oncotarget.10744 10.1016/j.cell.2011.06.034 10.1038/ncomms10893 10.1016/S0021-9258(17)38989-5 10.1016/j.cmet.2008.07.007 10.1111/boc.201300011 10.1152/ajpendo.90958.2008 10.1073/pnas.1018854108 10.1038/sj.pcan.4500879 10.1155/2012/539426 10.1002/ijc.29261 10.1016/j.bbalip.2008.10.010 10.1016/j.canlet.2017.07.027 10.5539/gjhs.v8n7p18 10.1016/j.ccell.2018.03.001 10.1074/jbc.M314032200 10.1080/01635581.2013.775316 10.1038/s41580-018-0085-z 10.2217/clp.10.67 10.1002/embr.201338119 10.1038/ncb3441 10.1016/j.bbalip.2009.09.005 10.2337/db14-0582 10.1016/j.bbrc.2015.08.054 10.1074/jbc.M504041200 10.1038/s41416-018-0221-8 10.1155/2017/9173090 10.1038/ncb3341 10.1074/jbc.M212665200 10.1126/science.1164097 10.1158/0008-5472.CAN-15-1970 10.1074/jbc.270.43.25578 10.1242/dev.121723 10.1039/C9RA90051A 10.1161/ATVBAHA.110.207449 10.1016/j.cell.2015.08.015 10.1073/pnas.0403390101 10.1074/jbc.M405522200 10.1038/nchembio.2238 10.18632/oncotarget.5359 10.1038/s41586-018-0343-4 10.1056/NEJMoa1201735 10.1038/nrc1143 10.1083/jcb.200703099 10.1016/j.tem.2018.06.002 10.1158/2326-6066.CIR-15-0146 10.1371/journal.pone.0005137 10.18632/oncotarget.15494 10.18632/oncotarget.19167 10.1016/j.ccell.2014.12.002 10.1158/0008-5472.CAN-04-2933 10.1038/s41388-017-0093-z 10.1253/circj.66.1087 10.3181/0711-MR-311 10.1074/jbc.M111.262816 10.1016/j.cmet.2013.04.010 10.1038/oncsis.2017.4 10.1038/nm1662 10.1073/pnas.91.14.6379 10.1111/cas.13339 10.1091/mbc.e10-01-0073 10.1158/0008-5472.CAN-09-3871 10.1016/S0092-8674(00)80696-0 10.1242/dmm.011338 10.1016/j.cmet.2011.06.002 10.1158/2159-8290.CD-18-1212 10.1016/j.ccr.2014.02.025 10.1126/science.296.5573.1655 10.1038/nature10602 10.1007/978-3-319-77736-8_3 10.1038/nrc3483 10.1080/01635581.2014.956262 10.1158/0008-5472.CAN-15-2613 10.1007/s11883-016-0611-4 10.1016/S0022-2275(20)39250-6 10.1159/000448357 10.1111/j.1600-065X.2012.01151.x 10.1016/j.ccr.2005.09.008 10.1186/1743-7075-7-3 10.1097/01.mco.0000232893.21050.15 10.1016/j.cell.2017.04.001 10.18632/oncotarget.15936 10.1038/nrc2809 10.1016/j.cell.2018.01.004 10.1016/j.cmet.2006.04.005 10.1194/jlr.R800049-JLR200 10.18632/oncotarget.14591 10.1126/science.aau3903 10.1074/jbc.M410302200 10.1016/j.tibs.2011.03.006 10.1016/j.cmet.2014.06.004 10.1074/jbc.M109.027748 10.1016/j.biopsych.2015.01.019 10.1073/pnas.1307237110 10.1016/j.cell.2014.11.020 10.4161/cc.25307 10.1186/1471-2407-12-25 10.1073/pnas.1617709114 10.1016/j.cmet.2007.11.015 10.1128/MCB.00579-08 10.1016/j.tibs.2014.06.005 10.1038/nature06322 10.1074/jbc.M204681200 10.1038/oncsis.2015.49 10.1038/nrc2222 10.1038/nm.2492 10.1073/pnas.200367597 10.1016/j.bbalip.2013.02.010 10.1111/febs.13681 10.1038/358157a0 10.1126/science.aab2674 10.1038/nrc969 10.1194/jlr.M004234 10.1016/j.celrep.2017.05.041 10.1016/j.jbior.2013.08.006 10.1038/onc.2015.179 10.1038/nrc.2016.89 10.18632/oncotarget.3629 10.18632/oncotarget.2344 10.1007/s10863-007-9081-2 10.1161/ATVBAHA.113.302677 10.1016/j.tem.2008.11.001 10.1074/jbc.M109.053280 10.1093/annonc/mdi239 10.1093/qjmed/hcr243 10.1016/j.bcp.2012.11.016 10.1080/14728222.2017.1381087 10.1242/jcs.01069 10.3858/emm.2008.40.4.445 10.1016/j.ccr.2012.05.016 10.1158/0008-5472.CAN-16-2008 10.1016/j.coph.2012.07.006 10.1007/s13238-014-0082-8 10.1038/s41586-018-0316-7 10.1186/s13046-019-1210-3 10.1016/j.cell.2017.07.007 10.1038/nature07823 10.1097/MOL.0000000000000091 10.1016/j.molcel.2014.09.023 10.1016/j.celrep.2014.08.056 10.1016/j.cell.2012.01.058 10.1074/jbc.M109440200 10.1073/pnas.132128899 10.1158/0008-5472.CAN-10-2581 10.1126/science.7761838 10.1128/MCB.01254-05 10.1016/S0163-7827(03)00039-0 10.1128/MCB.00782-08 10.1016/j.cell.2017.02.004 10.1093/carcin/bgp014 10.1016/j.cmet.2013.05.017 10.1126/science.129.3345.334 10.1016/j.cell.2005.02.031 10.1016/j.jare.2018.03.005 10.7150/ijbs.27173 10.1016/j.plefa.2013.09.011 10.1016/j.biochi.2004.09.018 10.18632/oncotarget.25361 10.18632/oncotarget.9666 10.1242/jcs.019166 10.2353/ajpath.2006.050959 10.1158/1541-7786.MCR-10-0467 10.1016/j.prostaglandins.2019.106363 10.1016/j.bbrc.2009.05.085 10.1084/jem.20052124 10.1016/S0092-8674(00)80213-5 10.1161/01.HYP.0000163475.04421.e4 10.1016/j.jacl.2015.01.002 10.18632/oncotarget.25432 10.1080/15548627.2017.1349581 10.1186/s40170-016-0163-7 10.1038/ncomms11971 10.1126/scitranslmed.aau5758 10.1186/s40170-016-0146-8 10.3390/ijerph16010043 10.1186/s12964-019-0328-4 10.1186/bcr3480 10.3390/molecules23081941 10.1038/s41467-017-01181-4 10.1038/s41467-018-04987-y 10.1101/cshperspect.a006783 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2019 This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2019 – notice: This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7TO 7U9 7X7 7XB 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AN0 AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1038/s41416-019-0650-z |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest Central Student MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Proquest Nursing & Allied Health Source url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-1827 |
| EndPage | 22 |
| ExternalDocumentID | PMC6964678 31819192 10_1038_s41416_019_0650_z |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: Cancer Research UK grantid: C59824/A25044 |
| GroupedDBID | --- -Q- 0R~ 23N 36B 39C 4.4 406 53G 5GY 5RE 6J9 70F 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAWTL AAYZH AAZLF ABAKF ABLJU ABOCM ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACPRK ACRQY ACZOJ ADBBV ADFRT ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMYLF AN0 AOIJS ASPBG AVWKF AXYYD AZFZN BAWUL BBNVY BENPR BHPHI BKEYQ BKKNO BNQBC BPHCQ BVXVI C6C CCPQU CS3 DIK DNIVK DPUIP DU5 E3Z EAP EBLON EBS EE. EIOEI EMB ESX EX3 F5P FDQFY FEDTE FERAY FIGPU FRJ FSGXE FYUFA GX1 HCIFZ HMCUK HVGLF HYE HZ~ IH2 IWAJR JSO JZLTJ KQ8 M1P M7P NAO NAPCQ NQJWS O9- OK1 P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT ROL RPM SNX SNYQT SOHCF SOJ SRMVM SWTZT TAOOD TBHMF TDRGL TR2 UKHRP W2D WH7 WOW ~02 AAFWJ AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFFHD AFHIU AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PQGLB .55 .GJ 8WZ A6W ABAWZ ABDBF ACUHS AI. B0M CAG CGR COF CUY CVF EAD EAS EBC EBD ECM EIF EJD EMK EMOBN EPL FIZPM J5H M41 NPM SV3 TUS UDS VH1 X7M Y6R ZGI ~8M 3V. 7TO 7U9 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ H94 K9. LK8 PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c536t-d4ceb2e0881da52abd18e7c56e249cab547f9063acaf9a8f9b0330f1a7cc04fb3 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 1134 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000507526800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0007-0920 1532-1827 |
| IngestDate | Tue Nov 04 02:03:06 EST 2025 Sun Nov 09 13:48:10 EST 2025 Mon Oct 06 18:36:13 EDT 2025 Mon Jul 21 05:46:51 EDT 2025 Tue Nov 18 21:45:41 EST 2025 Sat Nov 29 02:47:30 EST 2025 Fri Feb 21 02:39:36 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c536t-d4ceb2e0881da52abd18e7c56e249cab547f9063acaf9a8f9b0330f1a7cc04fb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC6964678 |
| PMID | 31819192 |
| PQID | 2342388285 |
| PQPubID | 41855 |
| PageCount | 19 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6964678 proquest_miscellaneous_2323479158 proquest_journals_2342388285 pubmed_primary_31819192 crossref_citationtrail_10_1038_s41416_019_0650_z crossref_primary_10_1038_s41416_019_0650_z springer_journals_10_1038_s41416_019_0650_z |
| PublicationCentury | 2000 |
| PublicationDate | 2020-01-01 |
| PublicationDateYYYYMMDD | 2020-01-01 |
| PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | British journal of cancer |
| PublicationTitleAbbrev | Br J Cancer |
| PublicationTitleAlternate | Br J Cancer |
| PublicationYear | 2020 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Menendez, Vellon, Lupu (CR198) 2005; 16 Guillet-Deniau, Pichard, Kone, Esnous, Nieruchalski, Girard (CR31) 2004; 117 Wu, Daniels, Lee, Monaco (CR68) 2014; 2 Wang, Dubois (CR72) 2010; 10 CR162 Kamphorst, Cross, Fan, de Stanchina, Mathew, White (CR27) 2013; 110 Tang, Zhou, Hooi, Jiang, Lu (CR193) 2018; 16 Choi, Hedman, Sayedyahossein, Thapa, Sacks, Anderson (CR163) 2016; 18 Yokoyama, Wang, Briggs, Admon, Wu, Hua (CR43) 1993; 75 Zhou, Li, Meinkoth, Pittman (CR154) 2000; 151 Karlic, Thaler, Gerner, Grunt, Proestling, Haider (CR142) 2015; 208 CR153 Luo, Zha, Gage, Dunn, Hicks, Bennett (CR69) 2002; 62 Taniguchi, Kondo, Sajan, Luo, Bronson, Asano (CR111) 2006; 3 Semenza (CR113) 2007; 39 Wen, Lee, Zhu, Lee, Yun, Kim (CR218) 2019; 1864 Kanarek, Keys, Cantor, Lewis, Chan, Kunchok (CR222) 2018; 559 Fujino, West, Regan (CR182) 2002; 277 Zuckerman, Sokolov, Swet, Ahrens, Showlater, Iannitti (CR177) 2016; 7 Ma, Lau, Leung, Lo, Ho, Cheng (CR219) 2017; 67 Marr, Foglia, Terebiznik, Athenstaedt, Zaremberg (CR47) 2012; 287 Wright, Hou, Xu, Cortez, Potma, Tromberg (CR67) 2017; 114 Saxton, Sabatini (CR90) 2017; 168 Carrer, Trefely, Zhao, Campbell, Norgard, Schultz (CR140) 2019; 9 Wahl, Dresser, Wilder-Romans, Parsels, Zhao, Davis (CR16) 2017; 77 Ntambi, Miyazaki (CR37) 2004; 43 Li, Gao (CR109) 2014; 15 Nielsen, Nordestgaard, Bojesen (CR149) 2012; 367 Potze, di Franco, Kessler, Stassi, Medema (CR220) 2016; 11 Samovski, Sun, Pietka, Gross, Eckel, Su (CR18) 2015; 64 Jiang, Du, Wu (CR114) 2014; 5 Das, Ghosh-Choudhury, Mariappan, Kasinath, Choudhury (CR108) 2016; 310 Chantranupong, Scaria, Saxton, Gygi, Shen, Wyant (CR168) 2016; 165 Li, Saud, Young, Chen, Hua (CR214) 2015; 6 Wingo, Gallardo, Akbay, Liang, Contreras, Boren, Shimamura, Miller, Sharpless, Bardeesy, Kwiatkowski, Schorge, Wong, Castrillon (CR215) 2009; 4 Ravnskov, McCully, Rosch (CR151) 2012; 105 Beloribi-Djefaflia, Vasseur, Guillaumond (CR2) 2016; 5 Ricciotti, FitzGerald (CR181) 2011; 31 Pisanu, Noto, De Vitis, Morrone, Scognamiglio, Botti (CR221) 2017; 406 Brown, Goldstein (CR41) 1997; 89 Liu, Yin, Wu, Liu (CR54) 2014; 5 Hatzivassiliou, Zhao, Bauer, Andreadis, Shaw, Dhanak (CR34) 2005; 8 Cantley (CR74) 2002; 296 Monaco (CR4) 2017; 8 Bottcher, Bonavita, Chakravarty, Blees, Cabeza-Cabrerizo, Sammicheli (CR190) 2018; 172 Manning, Toker (CR79) 2017; 169 Huang, Liu, Guo, Su (CR115) 2018; 14 Kuwata, Hara (CR192) 2019; 144 Vriens, Christen, Parik, Broekaert, Yoshinaga, Talebi (CR57) 2019; 566 Medes, Thomas, Weinhouse (CR30) 1953; 13 Knott, Wagenblast, Khan, Kim, Soto, Wagner (CR223) 2018; 554 Mitsuishi, Taguchi, Kawatani, Shibata, Nukiwa, Aburatani (CR20) 2012; 22 Guri, Colombi, Dazert, Hindupur, Roszik, Moes (CR102) 2017; 32 Campbell, Russell, Choong, Montgomery, Ciavarella, Hooi (CR78) 2004; 64 Wolfson, Chantranupong, Saxton, Shen, Scaria, Cantor (CR167) 2016; 351 Hoxhaj, Ben-Sahra, Lockwood, Timson, Byles, Henning (CR89) 2019; 363 Olzmann, Carvalho (CR12) 2019; 20 Lewin, Schwerbrock, Lee, Coleman (CR49) 2004; 279 Ma, Chen, Erdjument-Bromage, Tempst, Pandolfi (CR98) 2005; 121 DiNicolantonio, McCarty, Chatterjee, Lavie, O'Keefe (CR224) 2014; 66 Migita, Takayama, Urano, Obinata, Ikeda, Soga (CR66) 2017; 108 Cosker, Shadan, van Diepen, Morgan, Li, Allen-Baume (CR160) 2008; 121 Greenhough, Smartt, Moore, Roberts, Williams, Paraskeva (CR185) 2009; 30 Basingab, Ahmadi, Morgan (CR189) 2016; 4 Castel, Ellis, Bago, Toska, Razavi, Carmona (CR105) 2016; 30 Cao, Pearman, Zimmerman, McIntyre, Prescott (CR195) 2000; 97 Zelenay, van der Veen, Bottcher, Snelgrove, Rogers, Acton (CR191) 2015; 162 Sheng, Yung, Chen, Chun (CR171) 2015; 142 Xing, Wang, Xia, Zou, Shao, Kwong (CR126) 2000; 6 Matsuzaka, Shimano, Yahagi, Kato, Atsumi, Yamamoto (CR36) 2007; 13 Lu (CR19) 2009; 30 Kuwata, Hara (CR194) 2015; 465 Gouw, Eberlin, Margulis, Sullivan, Toal, Tong (CR99) 2017; 114 Pai, Soreghan, Szabo, Pavelka, Baatar, Tarnawski (CR184) 2002; 8 Wang, Wang, Brown, Daikoku, Ning, Shi (CR186) 2006; 203 Baenke, Peck, Miess, Schulze (CR29) 2013; 6 Waldhart, Dykstra, Peck, Boguslawski, Madaj, Wen (CR62) 2017; 19 Downward (CR97) 2003; 3 Balaban, Shearer, Lee, van Geldermalsen, Schreuder, Shtein (CR25) 2017; 5 Camarda, Zhou, Kohnz, Balakrishnan, Mahieu, Anderton, Eyob, Kajimura, Tward, Krings, Nomura, Goga (CR73) 2016; 22 Hawkins, Jackson, Stephens (CR77) 1992; 358 Torres-Ayuso, Daza-Martin, Martin-Perez, Avila-Flores, Merida (CR173) 2014; 5 Gao, Tchernyshyov, Chang, Lee, Kita, Ochi (CR60) 2009; 458 Porstmann, Santos, Griffiths, Cully, Wu, Leevers (CR93) 2008; 8 Menendez, Lupu (CR202) 2017; 21 CR127 Heiser, Sadanandam, Kuo, Benz, Goldstein, Ng (CR129) 2012; 109 Wagner, Stubiger, Veigel, Wuczkowski, Lanzerstorfer, Weghuber (CR132) 2017; 8 Heymsfield, Allison, Vasselli, Pietrobelli, Greenfield, Nunez (CR211) 1998; 280 Schug, Peck, Jones, Zhang, Grosskurth, Alam (CR33) 2015; 27 Tomek, Wagner, Varga, Singer, Karlic, Grunt (CR131) 2011; 9 Kruger, Beelen, Opdam, Sanders, van der Noort, Boven (CR80) 2018; 119 Yamamoto, Watanabe, Inoue, Nakagawa, Ishigaki, Matsuzaka (CR110) 2010; 51 Arteaga, Engelman (CR128) 2014; 25 Gomez-Cambronero (CR165) 2014; 54 Fruman, Chiu, Hopkins, Bagrodia, Cantley, Abraham (CR75) 2017; 170 Peterson, Sengupta, Harris, Carmack, Kang, Balderas (CR95) 2011; 146 Qin, Liao, Redmond, Young, Yuan, Chen (CR123) 2008; 28 Matsuzaki, Kita, Mabuchi, Matsuzawa, Nakaya, Oikawa (CR150) 2002; 66 Menendez, Lupu (CR122) 2017; 6 Yang, Goldstein, Hammer, Moon, Brown, Horton (CR42) 2001; 98 CR13 Auciello, Bulusu, Oon, Tait-Mulder, Berry, Bhattacharyya (CR179) 2019; 9 Kaidi, Williams, Paraskeva (CR188) 2007; 9 Lee, Carrer, Shah, Snyder, Wei, Venneti (CR136) 2014; 20 Li, Park, Ye, Kim, Kim (CR152) 2006; 168 Eberle, Hegarty, Bossard, Ferre, Foufelle (CR38) 2004; 86 Sparrow, Raetz (CR53) 1985; 260 Huang, Duran, Reina-Campos, Valencia, Castilla, Muller (CR23) 2018; 33 Vasudevan, Barbie, Davies, Rabinovsky, McNear, Kim (CR155) 2009; 16 Fritz, Mc (CR15) 1959; 129 Fenton, Hord, Ghosh, Gurzell (CR230) 2013; 89 Zhao, Prijic, Urban, Tisza, Zuo, Li (CR144) 2016; 76 Yu, Pestell, Lisanti, Pestell (CR138) 2012; 44 Abel (CR116) 2010; 48 CR28 Pelton, Freeman, Solomon (CR148) 2012; 12 Grabon, Khan, Bankaitis (CR158) 2015; 1851 Hagiwara, Cornu, Cybulski, Polak, Betz, Trapani (CR100) 2012; 61 Bensaad, Favaro, Lewis, Peck, Lord, Collins (CR21) 2014; 9 Lien, Lyssiotis, Juvekar, Hu, Asara, Cantley (CR64) 2016; 18 Nieman, Kenny, Penicka, Ladanyi, Buell-Gutbrod, Zillhardt (CR11) 2011; 17 Lengyel, Makowski, DiGiovanni, Kolonin (CR9) 2018; 4 Fukuda, Kelly, Semenza (CR187) 2003; 63 Wei, Leit, Kuai, Therrien, Rafi, Harwood (CR212) 2019; 568 Weigel, Veldwijk, Oakes, Seibold, Slynko, Liesenfeld (CR174) 2016; 7 Park, Coffey, Limoges, Le (CR205) 2018; 1063 Fujino, Xu, Regan (CR183) 2003; 278 Bilen, Ballantyne (CR209) 2016; 18 CR228 Ying, Kimmelman, Lyssiotis, Hua, Chu, Fletcher-Sananikone (CR58) 2012; 149 Kuzu, Noory, Robertson (CR146) 2016; 76 Wellen, Hatzivassiliou, Sachdeva, Bui, Cross, Thompson (CR135) 2009; 324 Hopkins, Pauli, Du, Wang, Li, Wu (CR76) 2018; 560 Shah, Carriveau, Li, Campbell, Kopinski, Lim (CR213) 2016; 7 Bryan, Olayanju, Goldring, Park (CR86) 2013; 85 Collins, Neville, Pinnick, Hodson, Ruyter, van Dijk (CR45) 2011; 52 Carter, Kennedy (CR52) 1966; 7 Lemus, Mendivil (CR206) 2015; 9 Adams, Reitz, De Brabander, Feramisco, Li, Brown (CR39) 2004; 279 Patterson, Wall, Fitzgerald, Ross, Stanton (CR226) 2012; 2012 Ladanyi, Mukherjee, Kenny, Johnson, Mitra, Sundaresan (CR7) 2018; 37 Yu, Liu, Cantley (CR125) 2002; 277 Buckley, Duke, Heuer, O'Farrell, Wagman, McCulloch (CR199) 2017; 177 Toschi, Lee, Xu, Garcia, Gadir, Foster (CR166) 2009; 29 Kim, Song, Yoo, Choe, Park, Kim (CR104) 2004; 279 Liu, Li, Wu, Cho (CR139) 2017; 8 Wu, Li, Li, Sun, Zhu, Wang (CR24) 2019; 38 Rajaei, Mowla, Ghorbani, Bahadoram, Bahadoram, Dargahi-Malamir (CR227) 2015; 8 Yoon, Sun, Arauz, Jiang, Chen (CR169) 2011; 286 Ye, Tu (CR133) 2018; 29 Wendel, Lewin, Coleman (CR48) 2009; 1791 Mendoza, Er, Blenis (CR124) 2011; 36 CR55 Czech (CR164) 2000; 100 Li, Qian, Lu (CR137) 2017; 13 Frigo, Howe, Wittmann, Brunner, Cushman, Wang (CR216) 2011; 71 Menendez, Lupu (CR121) 2006; 9 Rysman, Brusselmans, Scheys, Timmermans, Derua, Munck (CR143) 2010; 70 Menendez (CR81) 2010; 1801 Cunningham, Rodgers, Arlow, Vazquez, Mootha, Puigserver (CR91) 2007; 450 Lee, Zheng, Cho, Jang, England, Dempsey (CR96) 2017; 171 Heilos, Rohrl, Pirker, Englinger, Baier, Mohr (CR145) 2018; 9 Tzatsos (CR120) 2009; 284 Veigel, Wagner, Stubiger, Wuczkowski, Filipits, Horvat (CR200) 2015; 136 Gutierrez, Rosenberg, Macdougall, Hanselman, Margulies, Strange (CR207) 2014; 34 CR63 Kim, Yun, Do, Kim, Cho, Suh (CR178) 2008; 40 Mayas, Ortega, Macías-González, Bernal, Gómez-Huelgas, Fernández-Real, Tinahones (CR201) 2010; 7 Johnson, Milner, Makowski (CR22) 2012; 249 Dai, Li, Bai, Yang, Liu, Zhan (CR71) 2015; 5 Ren, Federico, Huang, Sunkara, Drennan, Frohman (CR50) 2010; 21 Willier, Butt, Grunewald (CR176) 2013; 105 Simopoulos (CR225) 2008; 233 Apte, Cavazos, Whelan, Degraffenried (CR229) 2013; 65 Nieman, Romero, Van Houten, Lengyel (CR10) 2013; 1831 Thupari, Landree, Ronnett, Kuhajda (CR204) 2002; 99 Yuneva, Zamboni, Oefner, Sachidanandam, Lazebnik (CR61) 2007; 178 Kagan, Mao, Qu, Angeli, Doll, Croix (CR196) 2017; 13 Patra, Hay (CR88) 2014; 39 Cho, Han (CR172) 2017; 40 Cui, Xing, Wang, Liu, Qiu, Ying (CR85) 2017; 8 Savage, Petersen, Shulman (CR118) 2005; 45 Gasser, Inuzuka, Lau, Wei, Beroukhim, Toker (CR156) 2014; 56 Yecies, Zhang, Menon, Liu, Yecies, Lipovsky (CR103) 2011; 14 Menendez, Vellon, Mehmi, Oza, Ropero, Colomer (CR82) 2004; 101 Valdes-Rives, Gonzalez-Arenas (CR175) 2017; 2017 Takeuchi, Reue (CR51) 2009; 296 CR8 Aronova, Wedaman, Aronov, Fontes, Ramos, Hammock (CR106) 2008; 7 Kinnaird, Zhao, Wellen, Michelakis (CR134) 2016; 16 Nile, Bankaitis, Grabon (CR159) 2010; 5 Chi, Guo, Wilmott, Guo, Yan, Wang (CR157) 2015; 6 Collins, Neville, Hoppa, Frayn (CR46) 2010; 285 Carracedo, Cantley, Pandolfi (CR14) 2013; 13 Menendez, Lupu (CR65) 2007; 7 CR83 Berwick, Hers, Heesom, Moule, Tavare (CR84) 2002; 277 Sun, Li, Goldstein, Brown (CR40) 2005; 280 Makinoshima, Takita, Saruwatari, Umemura, Obata, Ishii (CR112) 2015; 290 Hu CL Arteaga (650_CR128) 2014; 25 G Medes (650_CR30) 1953; 13 CA Lyssiotis (650_CR59) 2013; 12 D Veigel (650_CR200) 2015; 136 HQ Ying (650_CR58) 2012; 149 L Qin (650_CR123) 2008; 28 YC Li (650_CR152) 2006; 168 R Pai (650_CR184) 2002; 8 JA Menendez (650_CR81) 2010; 1801 JK Park (650_CR205) 2018; 1063 P Castel (650_CR105) 2016; 30 J Yang (650_CR42) 2001; 98 G Hatzivassiliou (650_CR34) 2005; 8 X Sheng (650_CR171) 2015; 142 S Filippov (650_CR208) 2014; 25 A Greenhough (650_CR185) 2009; 30 P Gao (650_CR60) 2009; 458 AR Johnson (650_CR22) 2012; 249 HJ Wright (650_CR67) 2017; 114 K Shafique (650_CR147) 2012; 12 A Toschi (650_CR166) 2009; 29 GL Semenza (650_CR113) 2007; 39 JF Huang (650_CR23) 2018; 33 X Wu (650_CR68) 2014; 2 Y Guri (650_CR102) 2017; 32 DR Wahl (650_CR16) 2017; 77 S Zelenay (650_CR191) 2015; 162 AM Gouw (650_CR99) 2017; 114 A Ladanyi (650_CR7) 2018; 37 L Ma (650_CR98) 2005; 121 S Balaban (650_CR25) 2017; 5 JR Carter (650_CR52) 1966; 7 P Fagone (650_CR1) 2009; 50 IG Campbell (650_CR78) 2004; 64 C Yokoyama (650_CR43) 1993; 75 X Huang (650_CR115) 2018; 14 AA Wendel (650_CR48) 2009; 1791 A Carrer (650_CR140) 2019; 9 650_CR162 KM Nieman (650_CR11) 2011; 17 Q Wu (650_CR24) 2019; 38 W Zhao (650_CR144) 2016; 76 I Guillet-Deniau (650_CR31) 2004; 117 HK Bryan (650_CR86) 2013; 85 X Li (650_CR109) 2014; 15 650_CR8 M Yuneva (650_CR61) 2007; 178 H Liu (650_CR197) 2008; 7 F Baenke (650_CR29) 2013; 6 PT Hawkins (650_CR77) 1992; 358 JM Ntambi (650_CR37) 2004; 43 SC Lu (650_CR19) 2009; 30 SJH Ricoult (650_CR94) 2016; 35 650_CR153 KM Vasudevan (650_CR155) 2009; 16 LP Sun (650_CR40) 2005; 280 KC Patra (650_CR88) 2014; 39 U Ravnskov (650_CR151) 2012; 105 CF Yu (650_CR125) 2002; 277 FS Basingab (650_CR189) 2016; 4 R Wagner (650_CR132) 2017; 8 K Bensaad (650_CR21) 2014; 9 650_CR13 SB Heymsfield (650_CR211) 1998; 280 AP Simopoulos (650_CR225) 2008; 233 ZT Schug (650_CR33) 2015; 27 ED Abel (650_CR116) 2010; 48 I Ben-Sahra (650_CR92) 2016; 351 H Makinoshima (650_CR112) 2015; 290 A Grabon (650_CR158) 2015; 1851 M Tomar (650_CR210) 2019; 9 G Hoxhaj (650_CR89) 2019; 363 GD Lopaschuk (650_CR117) 2016; 68 K Vriens (650_CR57) 2019; 566 JS Roe (650_CR141) 2017; 170 EK Kim (650_CR178) 2008; 40 E Rysman (650_CR143) 2010; 70 A Tzatsos (650_CR120) 2009; 284 Z Yu (650_CR138) 2012; 44 K Tomek (650_CR131) 2011; 9 SF Nielsen (650_CR149) 2012; 367 D Wang (650_CR186) 2006; 203 JM Collins (650_CR46) 2010; 285 AN Waldhart (650_CR62) 2017; 19 L Chantranupong (650_CR168) 2016; 165 JA Menendez (650_CR65) 2007; 7 LC Cantley (650_CR74) 2002; 296 JA Gasser (650_CR156) 2014; 56 XF Dai (650_CR71) 2015; 5 DZ Wang (650_CR72) 2010; 10 A Kaidi (650_CR188) 2007; 9 JA Menendez (650_CR121) 2006; 9 BD Manning (650_CR79) 2017; 169 J Luo (650_CR69) 2002; 62 LM Heiser (650_CR129) 2012; 109 A Kinnaird (650_CR134) 2016; 16 JH Cho (650_CR172) 2017; 40 S Choi (650_CR163) 2016; 18 OF Kuzu (650_CR146) 2016; 76 S Shah (650_CR213) 2016; 7 OJ Shah (650_CR119) 2006; 26 Roman Camarda (650_CR73) 2016; 22 H Karlic (650_CR142) 2015; 208 YF Cui (650_CR85) 2017; 8 A Carracedo (650_CR14) 2013; 13 Shana N. Wingo (650_CR215) 2009; 4 F Das (650_CR108) 2016; 310 CP Sparrow (650_CR53) 1985; 260 TR Peterson (650_CR95) 2011; 146 SA Apte (650_CR229) 2013; 65 A Kauffmann-Zeh (650_CR161) 1995; 268 TW Grunt (650_CR130) 2009; 385 MS Brown (650_CR41) 1997; 89 Y Liu (650_CR70) 2006; 9 P Jiang (650_CR114) 2014; 5 S Beloribi-Djefaflia (650_CR2) 2016; 5 TM Lewin (650_CR49) 2004; 279 JT Cunningham (650_CR91) 2007; 450 JP Bottcher (650_CR190) 2018; 172 W Li (650_CR214) 2015; 6 S Aronova (650_CR106) 2008; 7 MC Mendoza (650_CR124) 2011; 36 JA Menendez (650_CR202) 2017; 21 650_CR55 B Peck (650_CR56) 2016; 283 A Hagiwara (650_CR100) 2012; 61 C Weigel (650_CR174) 2016; 7 N Marr (650_CR47) 2012; 287 JL Yecies (650_CR103) 2011; 14 H Fujino (650_CR183) 2003; 278 IB Fritz (650_CR15) 1959; 129 E Ricciotti (650_CR181) 2011; 31 MN Chi (650_CR157) 2015; 6 JJ DiNicolantonio (650_CR224) 2014; 66 M Matsuzaki (650_CR150) 2002; 66 D Eberle (650_CR38) 2004; 86 FP Kuhajda (650_CR35) 1994; 91 SJ Humphrey (650_CR101) 2013; 17 SA Valdes-Rives (650_CR175) 2017; 2017 D Samovski (650_CR18) 2015; 64 KM Nieman (650_CR10) 2013; 1831 RL Wolfson (650_CR167) 2016; 351 FR Auciello (650_CR179) 2019; 9 DA Fruman (650_CR75) 2017; 170 DB Savage (650_CR118) 2005; 45 P Torres-Ayuso (650_CR173) 2014; 5 K Pelton (650_CR148) 2012; 12 CM Metallo (650_CR32) 2012; 481 SA Comerford (650_CR217) 2014; 159 MJ Gutierrez (650_CR207) 2014; 34 VS Hanna (650_CR180) 2018; 11 SRV Knott (650_CR223) 2018; 554 650_CR28 HL Zhou (650_CR154) 2000; 151 F Rohrig (650_CR3) 2016; 16 D Heilos (650_CR145) 2018; 9 BD Hopkins (650_CR76) 2018; 560 O Bilen (650_CR209) 2016; 18 E Currie (650_CR26) 2013; 18 T Matsuzaka (650_CR36) 2007; 13 H Ren (650_CR50) 2010; 21 H Wen (650_CR218) 2019; 1864 EC Lien (650_CR64) 2016; 18 X Xing (650_CR126) 2000; 6 DC Berwick (650_CR84) 2002; 277 MP Czech (650_CR164) 2000; 100 T Migita (650_CR66) 2017; 108 JM Collins (650_CR45) 2011; 52 Y Cao (650_CR195) 2000; 97 T Porstmann (650_CR93) 2008; 8 J Gomez-Cambronero (650_CR165) 2014; 54 E Patterson (650_CR226) 2012; 2012 E Lengyel (650_CR9) 2018; 4 E Rajaei (650_CR227) 2015; 8 G Pascual (650_CR17) 2017; 541 KH Kim (650_CR104) 2004; 279 JA Menendez (650_CR82) 2004; 101 G Lee (650_CR96) 2017; 171 DE Frigo (650_CR216) 2011; 71 JA Olzmann (650_CR12) 2019; 20 H Fujino (650_CR182) 2002; 277 ME Pisanu (650_CR221) 2017; 406 650_CR228 JA Menendez (650_CR122) 2017; 6 H Kuwata (650_CR194) 2015; 465 X Liu (650_CR54) 2014; 5 DK Cozzoli (650_CR107) 2016; 79 Y Mitsuishi (650_CR20) 2012; 22 JN Thupari (650_CR204) 2002; 99 CM Taniguchi (650_CR111) 2006; 3 HN Lemus (650_CR206) 2015; 9 CM Adams (650_CR39) 2004; 279 JA Menendez (650_CR198) 2005; 16 R Fukuda (650_CR187) 2003; 63 N Liu (650_CR139) 2017; 8 ME Monaco (650_CR4) 2017; 8 PJ Fernandez-Marcos (650_CR87) 2016; 7 S Willier (650_CR176) 2013; 105 650_CR83 J Wei (650_CR212) 2019; 568 X Li (650_CR137) 2017; 13 Y Tang (650_CR193) 2018; 16 L Potze (650_CR220) 2016; 11 H Kuwata (650_CR192) 2019; 144 X Su (650_CR5) 2009; 20 María D Mayas (650_CR201) 2010; 7 V Zuckerman (650_CR177) 2016; 7 MK Bennett (650_CR44) 1995; 270 T Yamamoto (650_CR110) 2010; 51 CQ Ye (650_CR133) 2018; 29 650_CR127 KE Wellen (650_CR135) 2009; 324 RA Saxton (650_CR90) 2017; 168 AH Nile (650_CR159) 2010; 5 D Buckley (650_CR199) 2017; 177 N Kanarek (650_CR222) 2018; 559 JI Fenton (650_CR230) 2013; 89 VE Kagan (650_CR196) 2017; 13 JJ Kamphorst (650_CR27) 2013; 110 K Takeuchi (650_CR51) 2009; 296 MS Yoon (650_CR169) 2011; 286 J Downward (650_CR97) 2003; 3 MKF Ma (650_CR219) 2017; 67 KE Cosker (650_CR160) 2008; 121 JV Lee (650_CR136) 2014; 20 GB Mills (650_CR170) 2003; 3 650_CR63 YY Zaytseva (650_CR203) 2018; 9 D Calvo (650_CR6) 1998; 39 DT Kruger (650_CR80) 2018; 119 |
| References_xml | – volume: 52 start-page: 1683 year: 2011 end-page: 1692 ident: CR45 article-title: De novo lipogenesis in the differentiating human adipocyte can provide all fatty acids necessary for maturation publication-title: J. Lipid Res. doi: 10.1194/jlr.M012195 – volume: 5 start-page: 2929 year: 2015 end-page: 2943 ident: CR71 article-title: Breast cancer intrinsic subtype classification, clinical use and future trends publication-title: Am. J. Cancer Res. – volume: 287 start-page: 10251 year: 2012 end-page: 10264 ident: CR47 article-title: Controlling lipid fluxes at glycerol-3-phosphate acyltransferase step in yeast: unique contribution of Gat1p to oleic acid-induced lipid particle formation publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.314112 – volume: 568 start-page: 566 year: 2019 end-page: 570 ident: CR212 article-title: An allosteric mechanism for potent inhibition of human ATP-citrate lyase publication-title: Nature doi: 10.1038/s41586-019-1094-6 – volume: 310 start-page: C583 year: 2016 end-page: C596 ident: CR108 article-title: Hydrophobic motif site-phosphorylated protein kinase CbetaII between mTORC2 and Akt regulates high glucose-induced mesangial cell hypertrophy publication-title: Am. J. Physiol. Cell Physiol. doi: 10.1152/ajpcell.00266.2015 – volume: 44 start-page: 2144 year: 2012 end-page: 2151 ident: CR138 article-title: Cancer stem cells publication-title: Int J. Biochem Cell Biol. doi: 10.1016/j.biocel.2012.08.022 – volume: 30 start-page: 229 year: 2016 end-page: 242 ident: CR105 article-title: PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3Kalpha inhibition publication-title: Cancer Cell. doi: 10.1016/j.ccell.2016.06.004 – volume: 151 start-page: 483 year: 2000 end-page: 494 ident: CR154 article-title: Akt regulates cell survival and apoptosis at a postmitochondrial level publication-title: J. Cell Biol. doi: 10.1083/jcb.151.3.483 – volume: 32 start-page: 807 year: 2017 end-page: 823.e12 ident: CR102 article-title: mTORC2 promotes tumorigenesis via lipid synthesis publication-title: Cancer Cell. doi: 10.1016/j.ccell.2017.11.011 – volume: 39 start-page: 777 year: 1998 end-page: 788 ident: CR6 article-title: Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)32566-9 – volume: 351 start-page: 728 year: 2016 end-page: 733 ident: CR92 article-title: mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle publication-title: Science doi: 10.1126/science.aad0489 – volume: 40 start-page: 805 year: 2017 end-page: 813 ident: CR172 article-title: Phospholipase D and Its Essential Role in Cancer publication-title: Mol. Cells – volume: 290 start-page: 17495 year: 2015 end-page: 17504 ident: CR112 article-title: Signaling through the phosphatidylinositol 3-kinase (PI3K)/Mammalian target of rapamycin (mTOR) axis is responsible for aerobic glycolysis mediated by glucose transporter in epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma publication-title: J. Biol. Chem. doi: 10.1074/jbc.M115.660498 – volume: 16 start-page: 21 year: 2009 end-page: 32 ident: CR155 article-title: AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer publication-title: Cancer Cell. doi: 10.1016/j.ccr.2009.04.012 – volume: 75 start-page: 187 year: 1993 end-page: 197 ident: CR43 article-title: Srebp-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low-density-lipoprotein receptor gene publication-title: Cell doi: 10.1016/S0092-8674(05)80095-9 – volume: 541 start-page: 41 year: 2017 end-page: 45 ident: CR17 article-title: Targeting metastasis-initiating cells through the fatty acid receptor CD36 publication-title: Nature doi: 10.1038/nature20791 – volume: 22 start-page: 427 issue: 4 year: 2016 end-page: 432 ident: CR73 article-title: Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer publication-title: Nature Medicine doi: 10.1038/nm.4055 – volume: 67 start-page: 979 year: 2017 end-page: 990 ident: CR219 article-title: Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation publication-title: J. Hepatol. doi: 10.1016/j.jhep.2017.06.015 – volume: 30 start-page: 42 year: 2009 end-page: 59 ident: CR19 article-title: Regulation of glutathione synthesis publication-title: Mol. Asp. Med. doi: 10.1016/j.mam.2008.05.005 – volume: 13 start-page: 27 year: 1953 end-page: 29 ident: CR30 article-title: Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro publication-title: Cancer Res. – volume: 171 start-page: 1545 year: 2017 end-page: 1558.e18 ident: CR96 article-title: Post-transcriptional regulation of de novo lipogenesis by mTORC1-S6K1-SRPK2 signaling publication-title: Cell doi: 10.1016/j.cell.2017.10.037 – volume: 9 start-page: 416 year: 2019 end-page: 435 ident: CR140 article-title: Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-18-0567 – volume: 7 start-page: 2951 year: 2016 end-page: 2967 ident: CR177 article-title: Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells publication-title: Oncotarget doi: 10.18632/oncotarget.6696 – volume: 6 start-page: 189 year: 2000 end-page: 195 ident: CR126 article-title: The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis publication-title: Nat. Med. doi: 10.1038/72294 – volume: 16 start-page: 694 year: 2016 end-page: 707 ident: CR134 article-title: Metabolic control of epigenetics in cancer publication-title: Nat. Rev. Cancer doi: 10.1038/nrc.2016.82 – volume: 7 start-page: 263 year: 2008 end-page: 270 ident: CR197 article-title: A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-07-0445 – volume: 4 start-page: 374 year: 2018 end-page: 384 ident: CR9 article-title: Cancer as a matter of fat: the crosstalk between adipose tissue and tumors publication-title: Trends Cancer doi: 10.1016/j.trecan.2018.03.004 – volume: 1851 start-page: 724 year: 2015 end-page: 735 ident: CR158 article-title: Phosphatidylinositol transfer proteins and instructive regulation of lipid kinase biology publication-title: Biochim Biophys. Acta doi: 10.1016/j.bbalip.2014.12.011 – volume: 8 start-page: 289 year: 2002 end-page: 293 ident: CR184 article-title: Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy publication-title: Nat. Med. doi: 10.1038/nm0302-289 – volume: 277 start-page: 19382 year: 2002 end-page: 19388 ident: CR125 article-title: ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase publication-title: J. Biol. Chem. doi: 10.1074/jbc.M200732200 – volume: 5 year: 2014 ident: CR54 article-title: Structure and mechanism of an intramembrane liponucleotide synthetase central for phospholipid biosynthesis publication-title: Nat. Commun. doi: 10.1038/ncomms5244 – volume: 280 start-page: 1596 year: 1998 end-page: 1600 ident: CR211 article-title: Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent—a randomized controlled trial publication-title: Jama-J. Am. Med Assoc. doi: 10.1001/jama.280.18.1596 – volume: 98 start-page: 13607 year: 2001 end-page: 13612 ident: CR42 article-title: Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene publication-title: Proc. Natl. Acad. Sci. Usa. doi: 10.1073/pnas.201524598 – volume: 566 start-page: 403 year: 2019 end-page: 406 ident: CR57 article-title: Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity publication-title: Nature doi: 10.1038/s41586-019-0904-1 – volume: 165 start-page: 153 year: 2016 end-page: 164 ident: CR168 article-title: The CASTOR proteins are arginine sensors for the mTORC1 pathway publication-title: Cell doi: 10.1016/j.cell.2016.02.035 – volume: 9 start-page: 210 year: 2007 end-page: U113 ident: CR188 article-title: Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia publication-title: Nat. Cell Biol. doi: 10.1038/ncb1534 – volume: 170 start-page: 605 year: 2017 end-page: 635 ident: CR75 article-title: The PI3K pathway in human disease publication-title: Cell doi: 10.1016/j.cell.2017.07.029 – volume: 177 start-page: 23 year: 2017 end-page: 31 ident: CR199 article-title: Fatty acid synthase—modern tumor cell biology insights into a classical oncology target publication-title: Pharmacol Therapeut. doi: 10.1016/j.pharmthera.2017.02.021 – volume: 208 start-page: 241 year: 2015 end-page: 252 ident: CR142 article-title: Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells publication-title: Cancer Genet. doi: 10.1016/j.cancergen.2015.03.008 – volume: 554 start-page: 378 year: 2018 end-page: 381 ident: CR223 article-title: Asparagine bioavailability governs metastasis in a model of breast cancer publication-title: Nature doi: 10.1038/nature25465 – ident: CR63 – volume: 11 start-page: 427 year: 2016 end-page: 433 ident: CR220 article-title: Betulinic acid kills colon cancer stem cells publication-title: Curr. Stem Cell Res Ther. doi: 10.2174/1574888X11666151203223512 – volume: 7 start-page: 50814 year: 2016 end-page: 50815 ident: CR87 article-title: NADPH: new oxygen for the ROS theory of aging publication-title: Oncotarget doi: 10.18632/oncotarget.10744 – volume: 146 start-page: 408 year: 2011 end-page: 420 ident: CR95 article-title: mTOR complex 1 regulates lipin 1 localization to control the SREBP Pathway publication-title: Cell doi: 10.1016/j.cell.2011.06.034 – volume: 7 year: 2016 ident: CR174 article-title: Epigenetic regulation of diacylglycerol kinase alpha promotes radiation-induced fibrosis publication-title: Nat. Commun. doi: 10.1038/ncomms10893 – volume: 260 start-page: 12084 year: 1985 end-page: 12091 ident: CR53 article-title: Purification and properties of the membrane-bound CDP-diglyceride synthetase from Escherichia coli publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(17)38989-5 – volume: 8 start-page: 224 year: 2008 end-page: 236 ident: CR93 article-title: SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth publication-title: Cell Metab. doi: 10.1016/j.cmet.2008.07.007 – volume: 105 start-page: 317 year: 2013 end-page: 333 ident: CR176 article-title: Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays publication-title: Biol. Cell. doi: 10.1111/boc.201300011 – volume: 296 start-page: E1195 year: 2009 end-page: E1209 ident: CR51 article-title: Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.90958.2008 – volume: 109 start-page: 2724 year: 2012 end-page: 2729 ident: CR129 article-title: Subtype and pathway specific responses to anticancer compounds in breast cancer publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1018854108 – volume: 9 start-page: 230 year: 2006 end-page: 234 ident: CR70 article-title: Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer publication-title: Prostate Cancer Prostatic Dis. doi: 10.1038/sj.pcan.4500879 – ident: CR162 – volume: 2012 start-page: 539426 year: 2012 ident: CR226 article-title: Health implications of high dietary omega-6 polyunsaturated Fatty acids publication-title: J. Nutr. Metab. doi: 10.1155/2012/539426 – volume: 136 start-page: 2078 year: 2015 end-page: 2090 ident: CR200 article-title: Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells publication-title: Int J. Cancer doi: 10.1002/ijc.29261 – volume: 1791 start-page: 501 year: 2009 end-page: 506 ident: CR48 article-title: Glycerol-3-phosphate acyltransferases: rate limiting enzymes of triacylglycerol biosynthesis publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbalip.2008.10.010 – volume: 406 start-page: 93 year: 2017 end-page: 104 ident: CR221 article-title: Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells publication-title: Cancer Lett. doi: 10.1016/j.canlet.2017.07.027 – volume: 8 start-page: 18 year: 2015 end-page: 25 ident: CR227 article-title: The effect of omega-3 fatty acids in patients with active rheumatoid arthritis receiving DMARDs therapy: double-blind randomized controlled trial publication-title: Glob. J. Health Sci. doi: 10.5539/gjhs.v8n7p18 – volume: 33 start-page: 770 year: 2018 ident: CR23 article-title: Adipocyte p62/SQSTM1 suppresses tumorigenesis through opposite regulations of metabolism in adipose tissue and tumor publication-title: Cancer Cell. doi: 10.1016/j.ccell.2018.03.001 – volume: 279 start-page: 13488 year: 2004 end-page: 13495 ident: CR49 article-title: Identification of a new glycerol-3-phosphate acyltransferase isoenzyme, mtGPAT2, in mitochondria publication-title: J. Biol. Chem. doi: 10.1074/jbc.M314032200 – volume: 65 start-page: 556 year: 2013 end-page: 562 ident: CR229 article-title: A low dietary ratio of omega-6 to omega-3 fatty acids may delay progression of prostate cancer publication-title: Nutr. Cancer doi: 10.1080/01635581.2013.775316 – volume: 20 start-page: 137 year: 2019 end-page: 155 ident: CR12 article-title: Dynamics and functions of lipid droplets publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/s41580-018-0085-z – volume: 5 start-page: 867 year: 2010 end-page: 897 ident: CR159 article-title: Mammalian diseases of phosphatidylinositol transfer proteins and their homologs publication-title: Clin. Lipidol. doi: 10.2217/clp.10.67 – volume: 15 start-page: 191 year: 2014 end-page: 198 ident: CR109 article-title: mTORC2 phosphorylates protein kinase Czeta to regulate its stability and activity publication-title: EMBO Rep. doi: 10.1002/embr.201338119 – volume: 18 start-page: 1324 year: 2016 end-page: 1335 ident: CR163 article-title: Agonist-stimulated phosphatidylinositol-3,4,5-trisphosphate generation by scaffolded phosphoinositide kinases publication-title: Nat. Cell Biol. doi: 10.1038/ncb3441 – volume: 1801 start-page: 381 year: 2010 end-page: 391 ident: CR81 article-title: Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives publication-title: Biochim Biophys. Acta doi: 10.1016/j.bbalip.2009.09.005 – volume: 64 start-page: 353 year: 2015 end-page: 359 ident: CR18 article-title: Regulation of AMPK activation by CD36 links fatty acid uptake to beta-oxidation publication-title: Diabetes doi: 10.2337/db14-0582 – volume: 465 start-page: 528 year: 2015 end-page: 533 ident: CR194 article-title: Inhibition of long-chain acyl-CoA synthetase 4 facilitates production of 5, 11-dihydroxyeicosatetraenoic acid via the cyclooxygenase-2 pathway publication-title: Biochem Biophys. Res Commun. doi: 10.1016/j.bbrc.2015.08.054 – volume: 280 start-page: 26483 year: 2005 end-page: 26490 ident: CR40 article-title: Insig required for sterol-mediated inhibition of Scap/SREBP binding to COPII proteins in vitro publication-title: J. Biol. Chem. doi: 10.1074/jbc.M504041200 – volume: 119 start-page: 832 year: 2018 end-page: 839 ident: CR80 article-title: Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences publication-title: Br. J. Cancer doi: 10.1038/s41416-018-0221-8 – volume: 2017 start-page: 9173090 year: 2017 ident: CR175 article-title: Autotaxin-lysophosphatidic acid: from inflammation to cancer development publication-title: Mediators Inflamm. doi: 10.1155/2017/9173090 – volume: 18 start-page: 572 year: 2016 end-page: 578 ident: CR64 article-title: Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer publication-title: Nat. Cell Biol. doi: 10.1038/ncb3341 – volume: 278 start-page: 12151 year: 2003 end-page: 12156 ident: CR183 article-title: Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases publication-title: J. Biol. Chem. doi: 10.1074/jbc.M212665200 – volume: 324 start-page: 1076 year: 2009 end-page: 1080 ident: CR135 article-title: ATP-citrate lyase links cellular metabolism to histone acetylation publication-title: Science doi: 10.1126/science.1164097 – volume: 76 start-page: 2037 year: 2016 end-page: 2049 ident: CR144 article-title: Candidate antimetastasis drugs suppress the metastatic capacity of breast cancer cells by reducing membrane fluidity publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-15-1970 – volume: 270 start-page: 25578 year: 1995 end-page: 25583 ident: CR44 article-title: Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways publication-title: J. Biol. Chem. doi: 10.1074/jbc.270.43.25578 – volume: 114 start-page: E6556 year: 2017 end-page: E6565 ident: CR67 article-title: CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation publication-title: Proc. Natl Acad. Sci. USA – volume: 142 start-page: 1390 year: 2015 end-page: 1395 ident: CR171 article-title: Lysophosphatidic acid signalling in development publication-title: Development doi: 10.1242/dev.121723 – volume: 9 start-page: 22288 year: 2019 ident: CR210 article-title: A clinical and computational study on anti-obesity effects of hydroxycitric acid (vol 9, pg 18578, 2019) publication-title: Rsc Adv. doi: 10.1039/C9RA90051A – volume: 31 start-page: 986 year: 2011 end-page: 1000 ident: CR181 article-title: Prostaglandins and Inflammation publication-title: Arterioscl Throm Vas. doi: 10.1161/ATVBAHA.110.207449 – volume: 162 start-page: 1257 year: 2015 end-page: 1270 ident: CR191 article-title: Cyclooxygenase-dependent tumor growth through evasion of immunity publication-title: Cell doi: 10.1016/j.cell.2015.08.015 – volume: 101 start-page: 10715 year: 2004 end-page: 10720 ident: CR82 article-title: Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0403390101 – volume: 279 start-page: 51999 year: 2004 end-page: 52006 ident: CR104 article-title: Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c publication-title: J. Biol. Chem. doi: 10.1074/jbc.M405522200 – volume: 13 start-page: 81 year: 2017 end-page: 90 ident: CR196 article-title: Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.2238 – volume: 6 start-page: 39891 year: 2015 end-page: 39907 ident: CR157 article-title: INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas publication-title: Oncotarget doi: 10.18632/oncotarget.5359 – volume: 560 start-page: 499 year: 2018 end-page: 503 ident: CR76 article-title: Suppression of insulin feedback enhances the efficacy of PI3K inhibitors publication-title: Nature doi: 10.1038/s41586-018-0343-4 – volume: 367 start-page: 1792 year: 2012 end-page: 1802 ident: CR149 article-title: Statin use and reduced cancer-related mortality publication-title: New Engl. J. Med. doi: 10.1056/NEJMoa1201735 – volume: 3 start-page: 582 year: 2003 end-page: 591 ident: CR170 article-title: The emerging role of lysophosphatidic acid in cancer publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1143 – volume: 178 start-page: 93 year: 2007 end-page: 105 ident: CR61 article-title: Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells publication-title: J. Cell Biol. doi: 10.1083/jcb.200703099 – volume: 29 start-page: 626 year: 2018 end-page: 637 ident: CR133 article-title: Sink into the epigenome: histones as repositories that influence cellular metabolism publication-title: Trends Endocrin Met. doi: 10.1016/j.tem.2018.06.002 – volume: 4 start-page: 400 year: 2016 end-page: 411 ident: CR189 article-title: IFN gamma-dependent interactions between ICAM-1 and LFA-1 counteract prostaglandin E2-Mediated inhibition of antitumor CTL responses publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-15-0146 – volume: 4 start-page: e5137 issue: 4 year: 2009 ident: CR215 article-title: Somatic LKB1 Mutations Promote Cervical Cancer Progression publication-title: PLoS ONE doi: 10.1371/journal.pone.0005137 – volume: 8 start-page: 29487 year: 2017 end-page: 29500 ident: CR4 article-title: Fatty acid metabolism in breast cancer subtypes publication-title: Oncotarget doi: 10.18632/oncotarget.15494 – volume: 8 start-page: 89315 year: 2017 end-page: 89325 ident: CR139 article-title: Acetylation and deacetylation in cancer stem-like cells publication-title: Oncotarget doi: 10.18632/oncotarget.19167 – volume: 27 start-page: 57 year: 2015 end-page: 71 ident: CR33 article-title: Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell Growth under Metabolic Stress publication-title: Cancer Cell. doi: 10.1016/j.ccell.2014.12.002 – volume: 64 start-page: 7678 year: 2004 end-page: 7681 ident: CR78 article-title: Mutation of the PIK3CA gene in ovarian and breast cancer publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-04-2933 – volume: 37 start-page: 2285 year: 2018 end-page: 2301 ident: CR7 article-title: Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis publication-title: Oncogene doi: 10.1038/s41388-017-0093-z – volume: 66 start-page: 1087 year: 2002 end-page: 1095 ident: CR150 article-title: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with Hypercholesterolemia—primary prevention cohort study of the Japan lipid intervention trial (J-LIT) publication-title: Circ. J. doi: 10.1253/circj.66.1087 – volume: 233 start-page: 674 year: 2008 end-page: 688 ident: CR225 article-title: The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases publication-title: Exp. Biol. Med. doi: 10.3181/0711-MR-311 – volume: 286 start-page: 29568 year: 2011 end-page: 29574 ident: CR169 article-title: Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.262816 – volume: 17 start-page: 1009 year: 2013 end-page: 1020 ident: CR101 article-title: Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2 publication-title: Cell Metab. doi: 10.1016/j.cmet.2013.04.010 – volume: 6 year: 2017 ident: CR122 article-title: Fatty acid synthase regulates estrogen receptor-alpha signaling in breast cancer cells publication-title: Oncogenesis doi: 10.1038/oncsis.2017.4 – volume: 13 start-page: 1193 year: 2007 end-page: 1202 ident: CR36 article-title: Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance publication-title: Nat. Med. doi: 10.1038/nm1662 – volume: 91 start-page: 6379 year: 1994 end-page: 6383 ident: CR35 article-title: Fatty acid synthesis: a potential selective target for antineoplastic therapy publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.91.14.6379 – volume: 108 start-page: 2011 year: 2017 end-page: 2021 ident: CR66 article-title: ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells publication-title: Cancer Sci. doi: 10.1111/cas.13339 – volume: 21 start-page: 3171 year: 2010 end-page: 3181 ident: CR50 article-title: A phosphatidic acid binding/nuclear localization motif determines lipin1 function in lipid metabolism and adipogenesis publication-title: Mol. Biol. Cell. doi: 10.1091/mbc.e10-01-0073 – volume: 70 start-page: 8117 year: 2010 end-page: 8126 ident: CR143 article-title: De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-3871 – volume: 100 start-page: 603 year: 2000 end-page: 606 ident: CR164 article-title: PIP2 and PIP3: Complex roles at the cell surface publication-title: Cell doi: 10.1016/S0092-8674(00)80696-0 – volume: 6 start-page: 1353 year: 2013 end-page: 1363 ident: CR29 article-title: Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development publication-title: Dis. Model Mech. doi: 10.1242/dmm.011338 – volume: 14 start-page: 21 year: 2011 end-page: 32 ident: CR103 article-title: Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-Dependent and Independent Pathways publication-title: Cell Metab. doi: 10.1016/j.cmet.2011.06.002 – ident: CR127 – volume: 9 start-page: 617 year: 2019 end-page: 627 ident: CR179 article-title: A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-18-1212 – volume: 25 start-page: 282 year: 2014 end-page: 303 ident: CR128 article-title: ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics publication-title: Cancer Cell. doi: 10.1016/j.ccr.2014.02.025 – volume: 296 start-page: 1655 year: 2002 end-page: 1657 ident: CR74 article-title: The phosphoinositide 3-kinase pathway publication-title: Science doi: 10.1126/science.296.5573.1655 – volume: 481 start-page: 380 year: 2012 end-page: 384 ident: CR32 article-title: Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia publication-title: Nature doi: 10.1038/nature10602 – volume: 1063 start-page: 33 year: 2018 end-page: 55 ident: CR205 article-title: The heterogeneity of lipid metabolism in cancer publication-title: Adv. Exp. Med Biol. doi: 10.1007/978-3-319-77736-8_3 – volume: 13 start-page: 227 year: 2013 end-page: 232 ident: CR14 article-title: Cancer metabolism: fatty acid oxidation in the limelight publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3483 – volume: 66 start-page: 1279 year: 2014 end-page: 1284 ident: CR224 article-title: A higher dietary ratio of long-chain omega-3 to total omega-6 fatty acids for prevention of COX-2-dependent adenocarcinomas publication-title: Nutr. Cancer doi: 10.1080/01635581.2014.956262 – volume: 2 start-page: 111 year: 2014 end-page: 120 ident: CR68 article-title: Lipid metabolism in prostate cancer publication-title: Am. J. Clin. Exp. Urol. – volume: 76 start-page: 2063 year: 2016 end-page: 2070 ident: CR146 article-title: The role of cholesterol in cancer publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-15-2613 – volume: 18 start-page: 61 year: 2016 ident: CR209 article-title: Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase publication-title: Curr. Atheroscler. Rep. doi: 10.1007/s11883-016-0611-4 – volume: 7 start-page: 678 year: 1966 end-page: 683 ident: CR52 article-title: Enzymatic synthesis of cytidine diphosphate diglyceride publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)39250-6 – volume: 68 start-page: 15 issue: Suppl 3 year: 2016 end-page: 20 ident: CR117 article-title: Fatty acid oxidation and its relation with insulin resistance and associated disorders publication-title: Ann. Nutr. Metab. doi: 10.1159/000448357 – volume: 249 start-page: 218 year: 2012 end-page: 238 ident: CR22 article-title: The inflammation highway: metabolism accelerates inflammatory traffic in obesity publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2012.01151.x – volume: 8 start-page: 311 year: 2005 end-page: 321 ident: CR34 article-title: ATP citrate lyase inhibition can suppress tumor cell growth publication-title: Cancer Cell. doi: 10.1016/j.ccr.2005.09.008 – volume: 7 start-page: 3 issue: 1 year: 2010 ident: CR201 article-title: Inverse relation between FASN expression in human adipose tissue and the insulin resistance level publication-title: Nutrition & Metabolism doi: 10.1186/1743-7075-7-3 – volume: 9 start-page: 346 year: 2006 end-page: 357 ident: CR121 article-title: Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells publication-title: Curr. Opin. Clin. Nutr. Metab. Care. doi: 10.1097/01.mco.0000232893.21050.15 – volume: 169 start-page: 381 year: 2017 end-page: 405 ident: CR79 article-title: AKT/PKB Signaling: Navigating the Network publication-title: Cell doi: 10.1016/j.cell.2017.04.001 – volume: 8 start-page: 32576 year: 2017 end-page: 32585 ident: CR85 article-title: NADPH accumulation is responsible for apoptosis in breast cancer cells induced by fatty acid synthase inhibition publication-title: Oncotarget doi: 10.18632/oncotarget.15936 – volume: 10 start-page: 181 year: 2010 end-page: 193 ident: CR72 article-title: Eicosanoids and cancer publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2809 – volume: 48 start-page: 5 year: 2010 end-page: 10 ident: CR116 article-title: Free fatty acid oxidation in insulin resistance and obesity publication-title: Heart Metab. – volume: 172 start-page: 1022 year: 2018 end-page: 1037.e14 ident: CR190 article-title: NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control publication-title: Cell doi: 10.1016/j.cell.2018.01.004 – volume: 3 start-page: 343 year: 2006 end-page: 353 ident: CR111 article-title: Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKC lambda/zeta publication-title: Cell Metab. doi: 10.1016/j.cmet.2006.04.005 – volume: 50 start-page: S311 year: 2009 end-page: S316 ident: CR1 article-title: Membrane phospholipid synthesis and endoplasmic reticulum function publication-title: J. Lipid Res. doi: 10.1194/jlr.R800049-JLR200 – volume: 8 start-page: 11600 year: 2017 end-page: 11613 ident: CR132 article-title: Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells publication-title: Oncotarget doi: 10.18632/oncotarget.14591 – volume: 363 start-page: 1088 year: 2019 end-page: 1092 ident: CR89 article-title: Direct stimulation of NADP(+) synthesis through Akt-mediated phosphorylation of NAD kinase publication-title: Science doi: 10.1126/science.aau3903 – volume: 279 start-page: 52772 year: 2004 end-page: 52780 ident: CR39 article-title: Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and insigs publication-title: J. Biol. Chem. doi: 10.1074/jbc.M410302200 – ident: CR8 – volume: 36 start-page: 320 year: 2011 end-page: 328 ident: CR124 article-title: The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation publication-title: Trends Biochem Sci. doi: 10.1016/j.tibs.2011.03.006 – volume: 20 start-page: 306 year: 2014 end-page: 319 ident: CR136 article-title: Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation publication-title: Cell Metab. doi: 10.1016/j.cmet.2014.06.004 – volume: 284 start-page: 22525 year: 2009 end-page: 22534 ident: CR120 article-title: Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of insulin receptor substrate-1 (IRS-1) and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109.027748 – volume: 79 start-page: 443 year: 2016 end-page: 451 ident: CR107 article-title: Protein kinase C epsilon activity in the nucleus accumbens and central nucleus of the amygdala mediates binge alcohol consumption publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2015.01.019 – ident: CR153 – volume: 110 start-page: 8882 year: 2013 end-page: 8887 ident: CR27 article-title: Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1307237110 – volume: 159 start-page: 1591 year: 2014 end-page: 1602 ident: CR217 article-title: Acetate dependence of tumors publication-title: Cell doi: 10.1016/j.cell.2014.11.020 – volume: 12 start-page: 1987 year: 2013 end-page: 1988 ident: CR59 article-title: Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance publication-title: Cell Cycle doi: 10.4161/cc.25307 – volume: 12 year: 2012 ident: CR147 article-title: Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up publication-title: Bmc Cancer doi: 10.1186/1471-2407-12-25 – volume: 114 start-page: 4300 year: 2017 end-page: 4305 ident: CR99 article-title: Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1617709114 – volume: 7 start-page: 148 year: 2008 end-page: 158 ident: CR106 article-title: Regulation of ceramide biosynthesis by TOR complex 2 publication-title: Cell Metab. doi: 10.1016/j.cmet.2007.11.015 – volume: 28 start-page: 5937 year: 2008 end-page: 5950 ident: CR123 article-title: The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression publication-title: Mol. Cell Biol. doi: 10.1128/MCB.00579-08 – volume: 39 start-page: 347 year: 2014 end-page: 354 ident: CR88 article-title: The pentose phosphate pathway and cancer publication-title: Trends Biochem Sci. doi: 10.1016/j.tibs.2014.06.005 – volume: 450 start-page: 736 year: 2007 end-page: U12 ident: CR91 article-title: mTOR controls mitochondrial oxidative function through a YY1-PGC-1 alpha transcriptional complex publication-title: Nature doi: 10.1038/nature06322 – volume: 277 start-page: 33895 year: 2002 end-page: 33900 ident: CR84 article-title: The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes publication-title: J. Biol. Chem. doi: 10.1074/jbc.M204681200 – volume: 5 year: 2016 ident: CR2 article-title: Lipid metabolic reprogramming in cancer cells publication-title: Oncogenesis doi: 10.1038/oncsis.2015.49 – volume: 7 start-page: 763 year: 2007 end-page: 777 ident: CR65 article-title: Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2222 – volume: 17 start-page: 1498 year: 2011 end-page: 1503 ident: CR11 article-title: Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth publication-title: Nat. Med. doi: 10.1038/nm.2492 – volume: 97 start-page: 11280 year: 2000 end-page: 11285 ident: CR195 article-title: Intracellular unesterified arachidonic acid signals apoptosis publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.200367597 – volume: 1831 start-page: 1533 year: 2013 end-page: 1541 ident: CR10 article-title: Adipose tissue and adipocytes support tumorigenesis and metastasis publication-title: Biochim Biophys. Acta doi: 10.1016/j.bbalip.2013.02.010 – volume: 283 start-page: 2767 year: 2016 end-page: 2778 ident: CR56 article-title: Lipid desaturation - the next step in targeting lipogenesis in cancer? publication-title: FEBS J. doi: 10.1111/febs.13681 – volume: 61 start-page: A27 year: 2012 end-page: A27 ident: CR100 article-title: Hepatic mTORC2 activates glycolysis and lipogenesis through akt, glucokinase and SREBP1c publication-title: Diabetes – volume: 358 start-page: 157 year: 1992 end-page: 159 ident: CR77 article-title: Platelet-derived growth factor stimulates synthesis of PtdIns(3,4,5)P3 by activating a PtdIns(4,5)P2 3-OH kinase publication-title: Nature doi: 10.1038/358157a0 – volume: 351 start-page: 43 year: 2016 end-page: 48 ident: CR167 article-title: Sestrin2 is a leucine sensor for the mTORC1 pathway publication-title: Science doi: 10.1126/science.aab2674 – volume: 3 start-page: 11 year: 2003 end-page: 22 ident: CR97 article-title: Targeting ras signalling pathways in cancer therapy publication-title: Nat. Rev. Cancer doi: 10.1038/nrc969 – volume: 51 start-page: 1859 year: 2010 end-page: 1870 ident: CR110 article-title: Protein kinase Cbeta mediates hepatic induction of sterol-regulatory element binding protein-1c by insulin publication-title: J. Lipid Res. doi: 10.1194/jlr.M004234 – volume: 63 start-page: 2330 year: 2003 end-page: 2334 ident: CR187 article-title: Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E-2 is mediated by hypoxia-inducible factor 1 publication-title: Cancer Res. – volume: 19 start-page: 2005 year: 2017 end-page: 2013 ident: CR62 article-title: Phosphorylation of TXNIP by AKT mediates acute influx of glucose in response to insulin publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.05.041 – volume: 54 start-page: 197 year: 2014 end-page: 206 ident: CR165 article-title: Phosphatidic acid, phospholipase D and tumorigenesis publication-title: Adv. Biol. Regul. doi: 10.1016/j.jbior.2013.08.006 – volume: 35 start-page: 1250 year: 2016 end-page: 1260 ident: CR94 article-title: Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP publication-title: Oncogene doi: 10.1038/onc.2015.179 – volume: 16 start-page: 732 year: 2016 end-page: 749 ident: CR3 article-title: The multifaceted roles of fatty acid synthesis in cancer publication-title: Nat. Rev. Cancer doi: 10.1038/nrc.2016.89 – ident: CR13 – volume: 16 start-page: 1390 year: 2018 end-page: 1396 ident: CR193 article-title: Fatty acid activation in carcinogenesis and cancer development: essential roles of long-chain acyl-CoA synthetases publication-title: Oncol. Lett. – volume: 6 start-page: 7365 year: 2015 end-page: 7378 ident: CR214 article-title: Targeting AMPK for cancer prevention and treatment publication-title: Oncotarget doi: 10.18632/oncotarget.3629 – ident: CR55 – ident: CR83 – volume: 5 start-page: 9710 year: 2014 end-page: 9726 ident: CR173 article-title: Diacylglycerol kinase a promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src publication-title: Oncotarget doi: 10.18632/oncotarget.2344 – volume: 39 start-page: 231 year: 2007 end-page: 234 ident: CR113 article-title: HIF-1 mediates the Warburg effect in clear cell renal carcinoma publication-title: J. Bioenerg. Biomembr. doi: 10.1007/s10863-007-9081-2 – volume: 62 start-page: 2220 year: 2002 end-page: 2226 ident: CR69 article-title: Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer publication-title: Cancer Res. – volume: 34 start-page: 676 year: 2014 end-page: 683 ident: CR207 article-title: Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus publication-title: Arterioscler Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.113.302677 – volume: 20 start-page: 72 year: 2009 end-page: 77 ident: CR5 article-title: Cellular fatty acid uptake: a pathway under construction publication-title: Trends Endocrinol. Metab. doi: 10.1016/j.tem.2008.11.001 – volume: 285 start-page: 6044 year: 2010 end-page: 6052 ident: CR46 article-title: De novo lipogenesis and stearoyl-CoA desaturase are coordinately regulated in the human adipocyte and protect against palmitate-induced cell injury publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109.053280 – volume: 16 start-page: 1253 year: 2005 end-page: 1267 ident: CR198 article-title: Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene publication-title: Ann. Oncol. doi: 10.1093/annonc/mdi239 – volume: 105 start-page: 383 year: 2012 end-page: 388 ident: CR151 article-title: The statin-low cholesterol-cancer conundrum publication-title: QJM doi: 10.1093/qjmed/hcr243 – volume: 85 start-page: 705 year: 2013 end-page: 717 ident: CR86 article-title: The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2012.11.016 – volume: 21 start-page: 1001 year: 2017 end-page: 1016 ident: CR202 article-title: Fatty acid synthase (FASN) as a therapeutic target in breast cancer publication-title: Expert Opin. Ther. Tar. doi: 10.1080/14728222.2017.1381087 – volume: 117 start-page: 1937 issue: Pt 10 year: 2004 end-page: 1944 ident: CR31 article-title: Glucose induces de novo lipogenesis in rat muscle satellite cells through a sterol-regulatory-element-binding-protein-1c-dependent pathway publication-title: J. Cell Sci. doi: 10.1242/jcs.01069 – volume: 40 start-page: 445 year: 2008 end-page: 452 ident: CR178 article-title: Lysophosphatidic acid induces cell migration through the selective activation of Akt1 publication-title: Exp. Mol. Med. doi: 10.3858/emm.2008.40.4.445 – volume: 22 start-page: 66 year: 2012 end-page: 79 ident: CR20 article-title: Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming publication-title: Cancer Cell. doi: 10.1016/j.ccr.2012.05.016 – ident: CR228 – volume: 77 start-page: 960 year: 2017 end-page: 970 ident: CR16 article-title: Glioblastoma therapy can be augmented by targeting IDH1-mediated NADPH biosynthesis publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-16-2008 – volume: 12 start-page: 751 year: 2012 end-page: 759 ident: CR148 article-title: Cholesterol and prostate cancer publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2012.07.006 – volume: 5 start-page: 592 year: 2014 end-page: 602 ident: CR114 article-title: Regulation of the pentose phosphate pathway in cancer publication-title: Protein Cell. doi: 10.1007/s13238-014-0082-8 – volume: 559 start-page: 632 year: 2018 end-page: 636 ident: CR222 article-title: Histidine catabolism is a major determinant of methotrexate sensitivity publication-title: Nature doi: 10.1038/s41586-018-0316-7 – volume: 38 start-page: 223 year: 2019 ident: CR24 article-title: Exosomes from the tumour-adipocyte interplay stimulate beige/brown differentiation and reprogram metabolism in stromal adipocytes to promote tumour progression publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-019-1210-3 – volume: 170 start-page: 875 year: 2017 end-page: 88 e20 ident: CR141 article-title: Enhancer reprogramming promotes pancreatic cancer metastasis publication-title: Cell doi: 10.1016/j.cell.2017.07.007 – volume: 458 start-page: 762 year: 2009 end-page: U100 ident: CR60 article-title: c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism publication-title: Nature doi: 10.1038/nature07823 – volume: 25 start-page: 309 year: 2014 end-page: 315 ident: CR208 article-title: LDL-cholesterol reduction in patients with hypercholesterolemia by modulation of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase publication-title: Curr. Opin. Lipidol. doi: 10.1097/MOL.0000000000000091 – volume: 56 start-page: 595 year: 2014 end-page: 607 ident: CR156 article-title: SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer publication-title: Mol. Cell. doi: 10.1016/j.molcel.2014.09.023 – volume: 9 start-page: 349 year: 2014 end-page: 365 ident: CR21 article-title: Fatty acid uptake and lipid storage induced by HIF-1 alpha contribute to cell growth and survival after hypoxia-reoxygenation publication-title: Cell Rep. doi: 10.1016/j.celrep.2014.08.056 – volume: 149 start-page: 656 year: 2012 end-page: 670 ident: CR58 article-title: Oncogenic kras maintains pancreatic tumors through regulation of anabolic glucose metabolism publication-title: Cell doi: 10.1016/j.cell.2012.01.058 – volume: 277 start-page: 2614 year: 2002 end-page: 2619 ident: CR182 article-title: Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109440200 – volume: 99 start-page: 9498 year: 2002 end-page: 9502 ident: CR204 article-title: C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.132128899 – volume: 71 start-page: 528 year: 2011 end-page: 537 ident: CR216 article-title: CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-10-2581 – volume: 268 start-page: 1188 year: 1995 end-page: 1190 ident: CR161 article-title: Requirement for phosphatidylinositol transfer protein in epidermal growth factor signaling publication-title: Science doi: 10.1126/science.7761838 – volume: 26 start-page: 6425 year: 2006 end-page: 6434 ident: CR119 article-title: Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis publication-title: Mol. Cell Biol. doi: 10.1128/MCB.01254-05 – volume: 43 start-page: 91 year: 2004 end-page: 104 ident: CR37 article-title: Regulation of stearoyl-CoA desaturases and role in metabolism publication-title: Prog. Lipid Res. doi: 10.1016/S0163-7827(03)00039-0 – volume: 29 start-page: 1411 year: 2009 end-page: 1420 ident: CR166 article-title: Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin publication-title: Mol. Cell Biol. doi: 10.1128/MCB.00782-08 – volume: 168 start-page: 960 year: 2017 end-page: 976 ident: CR90 article-title: mTOR signaling in growth, metabolism, and disease publication-title: Cell doi: 10.1016/j.cell.2017.02.004 – volume: 30 start-page: 377 year: 2009 end-page: 386 ident: CR185 article-title: The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment publication-title: Carcinogenesis doi: 10.1093/carcin/bgp014 – volume: 18 start-page: 153 year: 2013 end-page: 161 ident: CR26 article-title: Cellular fatty acid metabolism and cancer publication-title: Cell Metab. doi: 10.1016/j.cmet.2013.05.017 – volume: 129 start-page: 334 year: 1959 end-page: 335 ident: CR15 article-title: Effects of carnitine on fatty-acid oxidation by muscle publication-title: Science doi: 10.1126/science.129.3345.334 – volume: 121 start-page: 179 year: 2005 end-page: 193 ident: CR98 article-title: Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis publication-title: Cell doi: 10.1016/j.cell.2005.02.031 – volume: 11 start-page: 23 year: 2018 end-page: 32 ident: CR180 article-title: Synopsis of arachidonic acid metabolism: a review publication-title: J. Adv. Res. doi: 10.1016/j.jare.2018.03.005 – volume: 14 start-page: 1483 year: 2018 end-page: 1496 ident: CR115 article-title: The PI3K/AKT pathway in obesity and type 2 diabetes publication-title: Int J. Biol. Sci. doi: 10.7150/ijbs.27173 – volume: 1864 start-page: 413 year: 2019 end-page: 421 ident: CR218 article-title: Glucose-derived acetate and ACSS2 as key players in cisplatin resistance in bladder cancer publication-title: Bba-Mol. Cell Biol. L. – volume: 89 start-page: 379 year: 2013 end-page: 390 ident: CR230 article-title: Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes publication-title: Prostag Leukotr Ess. doi: 10.1016/j.plefa.2013.09.011 – volume: 86 start-page: 839 year: 2004 end-page: 848 ident: CR38 article-title: SREBP transcription factors: master regulators of lipid homeostasis publication-title: Biochimie doi: 10.1016/j.biochi.2004.09.018 – volume: 9 start-page: 24787 year: 2018 end-page: 24800 ident: CR203 article-title: Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer publication-title: Oncotarget doi: 10.18632/oncotarget.25361 – volume: 7 start-page: 43713 year: 2016 end-page: 43730 ident: CR213 article-title: Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism publication-title: Oncotarget doi: 10.18632/oncotarget.9666 – volume: 121 start-page: 796 issue: Pt 6 year: 2008 end-page: 803 ident: CR160 article-title: Regulation of PI3K signalling by the phosphatidylinositol transfer protein PITPalpha during axonal extension in hippocampal neurons publication-title: J. Cell Sci. doi: 10.1242/jcs.019166 – volume: 168 start-page: 1107 year: 2006 end-page: 1118 ident: CR152 article-title: Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents publication-title: Am. J. Pathol. doi: 10.2353/ajpath.2006.050959 – volume: 9 start-page: 1767 year: 2011 end-page: 1779 ident: CR131 article-title: Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-10-0467 – volume: 144 start-page: 106363 year: 2019 ident: CR192 article-title: Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/j.prostaglandins.2019.106363 – volume: 385 start-page: 454 year: 2009 end-page: 459 ident: CR130 article-title: Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells publication-title: Biochem Bioph Res Co. doi: 10.1016/j.bbrc.2009.05.085 – volume: 203 start-page: 941 year: 2006 end-page: 951 ident: CR186 article-title: CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer publication-title: J. Exp. Med. doi: 10.1084/jem.20052124 – volume: 89 start-page: 331 year: 1997 end-page: 340 ident: CR41 article-title: The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor publication-title: Cell doi: 10.1016/S0092-8674(00)80213-5 – volume: 45 start-page: 828 year: 2005 end-page: 833 ident: CR118 article-title: Mechanisms of insulin resistance in humans and possible links with inflammation publication-title: Hypertension doi: 10.1161/01.HYP.0000163475.04421.e4 – ident: CR28 – volume: 9 start-page: 384 year: 2015 end-page: 389 ident: CR206 article-title: Adenosine triphosphate citrate lyase: emerging target in the treatment of dyslipidemia publication-title: J. Clin. Lipidol. doi: 10.1016/j.jacl.2015.01.002 – volume: 9 start-page: 25661 year: 2018 end-page: 25680 ident: CR145 article-title: Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins publication-title: Oncotarget doi: 10.18632/oncotarget.25432 – volume: 13 start-page: 1790 year: 2017 end-page: 1791 ident: CR137 article-title: Local histone acetylation by ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy publication-title: Autophagy doi: 10.1080/15548627.2017.1349581 – volume: 5 start-page: 1 year: 2017 ident: CR25 article-title: Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration publication-title: Cancer Metab. doi: 10.1186/s40170-016-0163-7 – volume: 168 start-page: 960 year: 2017 ident: 650_CR90 publication-title: Cell doi: 10.1016/j.cell.2017.02.004 – ident: 650_CR63 doi: 10.1038/ncomms11971 – volume: 172 start-page: 1022 year: 2018 ident: 650_CR190 publication-title: Cell doi: 10.1016/j.cell.2018.01.004 – volume: 18 start-page: 61 year: 2016 ident: 650_CR209 publication-title: Curr. Atheroscler. Rep. doi: 10.1007/s11883-016-0611-4 – volume: 554 start-page: 378 year: 2018 ident: 650_CR223 publication-title: Nature doi: 10.1038/nature25465 – volume: 5 start-page: 2929 year: 2015 ident: 650_CR71 publication-title: Am. J. Cancer Res. – ident: 650_CR8 doi: 10.1126/scitranslmed.aau5758 – volume: 279 start-page: 52772 year: 2004 ident: 650_CR39 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M410302200 – volume: 7 start-page: 678 year: 1966 ident: 650_CR52 publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)39250-6 – volume: 170 start-page: 605 year: 2017 ident: 650_CR75 publication-title: Cell doi: 10.1016/j.cell.2017.07.029 – volume: 85 start-page: 705 year: 2013 ident: 650_CR86 publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2012.11.016 – volume: 277 start-page: 2614 year: 2002 ident: 650_CR182 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109440200 – volume: 89 start-page: 379 year: 2013 ident: 650_CR230 publication-title: Prostag Leukotr Ess. doi: 10.1016/j.plefa.2013.09.011 – volume: 39 start-page: 777 year: 1998 ident: 650_CR6 publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)32566-9 – volume: 4 start-page: 400 year: 2016 ident: 650_CR189 publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-15-0146 – volume: 9 start-page: 384 year: 2015 ident: 650_CR206 publication-title: J. Clin. Lipidol. doi: 10.1016/j.jacl.2015.01.002 – volume: 279 start-page: 13488 year: 2004 ident: 650_CR49 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M314032200 – volume: 16 start-page: 1390 year: 2018 ident: 650_CR193 publication-title: Oncol. Lett. – volume: 296 start-page: E1195 year: 2009 ident: 650_CR51 publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.90958.2008 – volume: 129 start-page: 334 year: 1959 ident: 650_CR15 publication-title: Science doi: 10.1126/science.129.3345.334 – volume: 29 start-page: 626 year: 2018 ident: 650_CR133 publication-title: Trends Endocrin Met. doi: 10.1016/j.tem.2018.06.002 – ident: 650_CR55 doi: 10.1186/s40170-016-0146-8 – volume: 27 start-page: 57 year: 2015 ident: 650_CR33 publication-title: Cancer Cell. doi: 10.1016/j.ccell.2014.12.002 – volume: 12 start-page: 1987 year: 2013 ident: 650_CR59 publication-title: Cell Cycle doi: 10.4161/cc.25307 – volume: 450 start-page: 736 year: 2007 ident: 650_CR91 publication-title: Nature doi: 10.1038/nature06322 – volume: 54 start-page: 197 year: 2014 ident: 650_CR165 publication-title: Adv. Biol. Regul. doi: 10.1016/j.jbior.2013.08.006 – volume: 165 start-page: 153 year: 2016 ident: 650_CR168 publication-title: Cell doi: 10.1016/j.cell.2016.02.035 – volume: 260 start-page: 12084 year: 1985 ident: 650_CR53 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(17)38989-5 – volume: 109 start-page: 2724 year: 2012 ident: 650_CR129 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1018854108 – volume: 114 start-page: 4300 year: 2017 ident: 650_CR99 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1617709114 – volume: 33 start-page: 770 year: 2018 ident: 650_CR23 publication-title: Cancer Cell. doi: 10.1016/j.ccell.2018.03.001 – volume: 45 start-page: 828 year: 2005 ident: 650_CR118 publication-title: Hypertension doi: 10.1161/01.HYP.0000163475.04421.e4 – volume: 114 start-page: E6556 year: 2017 ident: 650_CR67 publication-title: Proc. Natl Acad. Sci. USA – volume: 6 start-page: 189 year: 2000 ident: 650_CR126 publication-title: Nat. Med. doi: 10.1038/72294 – volume: 351 start-page: 728 year: 2016 ident: 650_CR92 publication-title: Science doi: 10.1126/science.aad0489 – volume: 406 start-page: 93 year: 2017 ident: 650_CR221 publication-title: Cancer Lett. doi: 10.1016/j.canlet.2017.07.027 – volume: 117 start-page: 1937 issue: Pt 10 year: 2004 ident: 650_CR31 publication-title: J. Cell Sci. doi: 10.1242/jcs.01069 – volume: 287 start-page: 10251 year: 2012 ident: 650_CR47 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.314112 – volume: 101 start-page: 10715 year: 2004 ident: 650_CR82 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0403390101 – volume: 16 start-page: 1253 year: 2005 ident: 650_CR198 publication-title: Ann. Oncol. doi: 10.1093/annonc/mdi239 – volume: 367 start-page: 1792 year: 2012 ident: 650_CR149 publication-title: New Engl. J. Med. doi: 10.1056/NEJMoa1201735 – ident: 650_CR228 doi: 10.3390/ijerph16010043 – volume: 566 start-page: 403 year: 2019 ident: 650_CR57 publication-title: Nature doi: 10.1038/s41586-019-0904-1 – volume: 66 start-page: 1279 year: 2014 ident: 650_CR224 publication-title: Nutr. Cancer doi: 10.1080/01635581.2014.956262 – volume: 9 start-page: 349 year: 2014 ident: 650_CR21 publication-title: Cell Rep. doi: 10.1016/j.celrep.2014.08.056 – volume: 51 start-page: 1859 year: 2010 ident: 650_CR110 publication-title: J. Lipid Res. doi: 10.1194/jlr.M004234 – volume: 5 start-page: 9710 year: 2014 ident: 650_CR173 publication-title: Oncotarget doi: 10.18632/oncotarget.2344 – volume: 29 start-page: 1411 year: 2009 ident: 650_CR166 publication-title: Mol. Cell Biol. doi: 10.1128/MCB.00782-08 – volume: 7 start-page: 148 year: 2008 ident: 650_CR106 publication-title: Cell Metab. doi: 10.1016/j.cmet.2007.11.015 – volume: 15 start-page: 191 year: 2014 ident: 650_CR109 publication-title: EMBO Rep. doi: 10.1002/embr.201338119 – volume: 7 start-page: 50814 year: 2016 ident: 650_CR87 publication-title: Oncotarget doi: 10.18632/oncotarget.10744 – volume: 66 start-page: 1087 year: 2002 ident: 650_CR150 publication-title: Circ. J. doi: 10.1253/circj.66.1087 – volume: 31 start-page: 986 year: 2011 ident: 650_CR181 publication-title: Arterioscl Throm Vas. doi: 10.1161/ATVBAHA.110.207449 – volume: 162 start-page: 1257 year: 2015 ident: 650_CR191 publication-title: Cell doi: 10.1016/j.cell.2015.08.015 – volume: 7 start-page: 3 issue: 1 year: 2010 ident: 650_CR201 publication-title: Nutrition & Metabolism doi: 10.1186/1743-7075-7-3 – volume: 9 start-page: 1767 year: 2011 ident: 650_CR131 publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-10-0467 – volume: 203 start-page: 941 year: 2006 ident: 650_CR186 publication-title: J. Exp. Med. doi: 10.1084/jem.20052124 – ident: 650_CR153 doi: 10.1186/s12964-019-0328-4 – volume: 89 start-page: 331 year: 1997 ident: 650_CR41 publication-title: Cell doi: 10.1016/S0092-8674(00)80213-5 – volume: 8 start-page: 289 year: 2002 ident: 650_CR184 publication-title: Nat. Med. doi: 10.1038/nm0302-289 – volume: 7 start-page: 43713 year: 2016 ident: 650_CR213 publication-title: Oncotarget doi: 10.18632/oncotarget.9666 – volume: 62 start-page: 2220 year: 2002 ident: 650_CR69 publication-title: Cancer Res. – volume: 279 start-page: 51999 year: 2004 ident: 650_CR104 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M405522200 – volume: 149 start-page: 656 year: 2012 ident: 650_CR58 publication-title: Cell doi: 10.1016/j.cell.2012.01.058 – volume: 14 start-page: 1483 year: 2018 ident: 650_CR115 publication-title: Int J. Biol. Sci. doi: 10.7150/ijbs.27173 – volume: 77 start-page: 960 year: 2017 ident: 650_CR16 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-16-2008 – volume: 13 start-page: 1193 year: 2007 ident: 650_CR36 publication-title: Nat. Med. doi: 10.1038/nm1662 – volume: 76 start-page: 2063 year: 2016 ident: 650_CR146 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-15-2613 – volume: 34 start-page: 676 year: 2014 ident: 650_CR207 publication-title: Arterioscler Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.113.302677 – volume: 105 start-page: 383 year: 2012 ident: 650_CR151 publication-title: QJM doi: 10.1093/qjmed/hcr243 – volume: 61 start-page: A27 year: 2012 ident: 650_CR100 publication-title: Diabetes – volume: 277 start-page: 19382 year: 2002 ident: 650_CR125 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M200732200 – volume: 4 start-page: e5137 issue: 4 year: 2009 ident: 650_CR215 publication-title: PLoS ONE doi: 10.1371/journal.pone.0005137 – volume: 9 start-page: 617 year: 2019 ident: 650_CR179 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-18-1212 – volume: 63 start-page: 2330 year: 2003 ident: 650_CR187 publication-title: Cancer Res. – volume: 1801 start-page: 381 year: 2010 ident: 650_CR81 publication-title: Biochim Biophys. Acta doi: 10.1016/j.bbalip.2009.09.005 – volume: 146 start-page: 408 year: 2011 ident: 650_CR95 publication-title: Cell doi: 10.1016/j.cell.2011.06.034 – volume: 13 start-page: 27 year: 1953 ident: 650_CR30 publication-title: Cancer Res. – volume: 110 start-page: 8882 year: 2013 ident: 650_CR27 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1307237110 – volume: 13 start-page: 81 year: 2017 ident: 650_CR196 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.2238 – volume: 278 start-page: 12151 year: 2003 ident: 650_CR183 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M212665200 – volume: 290 start-page: 17495 year: 2015 ident: 650_CR112 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M115.660498 – volume: 48 start-page: 5 year: 2010 ident: 650_CR116 publication-title: Heart Metab. – volume: 17 start-page: 1498 year: 2011 ident: 650_CR11 publication-title: Nat. Med. doi: 10.1038/nm.2492 – volume: 86 start-page: 839 year: 2004 ident: 650_CR38 publication-title: Biochimie doi: 10.1016/j.biochi.2004.09.018 – volume: 363 start-page: 1088 year: 2019 ident: 650_CR89 publication-title: Science doi: 10.1126/science.aau3903 – volume: 9 start-page: 24787 year: 2018 ident: 650_CR203 publication-title: Oncotarget doi: 10.18632/oncotarget.25361 – volume: 208 start-page: 241 year: 2015 ident: 650_CR142 publication-title: Cancer Genet. doi: 10.1016/j.cancergen.2015.03.008 – volume: 285 start-page: 6044 year: 2010 ident: 650_CR46 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109.053280 – volume: 3 start-page: 11 year: 2003 ident: 650_CR97 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc969 – volume: 75 start-page: 187 year: 1993 ident: 650_CR43 publication-title: Cell doi: 10.1016/S0092-8674(05)80095-9 – volume: 37 start-page: 2285 year: 2018 ident: 650_CR7 publication-title: Oncogene doi: 10.1038/s41388-017-0093-z – volume: 3 start-page: 343 year: 2006 ident: 650_CR111 publication-title: Cell Metab. doi: 10.1016/j.cmet.2006.04.005 – volume: 10 start-page: 181 year: 2010 ident: 650_CR72 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2809 – volume: 28 start-page: 5937 year: 2008 ident: 650_CR123 publication-title: Mol. Cell Biol. doi: 10.1128/MCB.00579-08 – volume: 168 start-page: 1107 year: 2006 ident: 650_CR152 publication-title: Am. J. Pathol. doi: 10.2353/ajpath.2006.050959 – volume: 13 start-page: 227 year: 2013 ident: 650_CR14 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3483 – volume: 324 start-page: 1076 year: 2009 ident: 650_CR135 publication-title: Science doi: 10.1126/science.1164097 – volume: 7 start-page: 2951 year: 2016 ident: 650_CR177 publication-title: Oncotarget doi: 10.18632/oncotarget.6696 – volume: 97 start-page: 11280 year: 2000 ident: 650_CR195 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.200367597 – volume: 2017 start-page: 9173090 year: 2017 ident: 650_CR175 publication-title: Mediators Inflamm. doi: 10.1155/2017/9173090 – volume: 121 start-page: 179 year: 2005 ident: 650_CR98 publication-title: Cell doi: 10.1016/j.cell.2005.02.031 – volume: 12 year: 2012 ident: 650_CR147 publication-title: Bmc Cancer doi: 10.1186/1471-2407-12-25 – volume: 233 start-page: 674 year: 2008 ident: 650_CR225 publication-title: Exp. Biol. Med. doi: 10.3181/0711-MR-311 – volume: 6 start-page: 1353 year: 2013 ident: 650_CR29 publication-title: Dis. Model Mech. doi: 10.1242/dmm.011338 – volume: 9 start-page: 25661 year: 2018 ident: 650_CR145 publication-title: Oncotarget doi: 10.18632/oncotarget.25432 – volume: 8 start-page: 224 year: 2008 ident: 650_CR93 publication-title: Cell Metab. doi: 10.1016/j.cmet.2008.07.007 – volume: 91 start-page: 6379 year: 1994 ident: 650_CR35 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.91.14.6379 – volume: 4 start-page: 374 year: 2018 ident: 650_CR9 publication-title: Trends Cancer doi: 10.1016/j.trecan.2018.03.004 – volume: 20 start-page: 72 year: 2009 ident: 650_CR5 publication-title: Trends Endocrinol. Metab. doi: 10.1016/j.tem.2008.11.001 – volume: 280 start-page: 1596 year: 1998 ident: 650_CR211 publication-title: Jama-J. Am. Med Assoc. doi: 10.1001/jama.280.18.1596 – volume: 268 start-page: 1188 year: 1995 ident: 650_CR161 publication-title: Science doi: 10.1126/science.7761838 – volume: 100 start-page: 603 year: 2000 ident: 650_CR164 publication-title: Cell doi: 10.1016/S0092-8674(00)80696-0 – volume: 20 start-page: 306 year: 2014 ident: 650_CR136 publication-title: Cell Metab. doi: 10.1016/j.cmet.2014.06.004 – volume: 19 start-page: 2005 year: 2017 ident: 650_CR62 publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.05.041 – volume: 7 start-page: 763 year: 2007 ident: 650_CR65 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2222 – volume: 277 start-page: 33895 year: 2002 ident: 650_CR84 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M204681200 – volume: 6 year: 2017 ident: 650_CR122 publication-title: Oncogenesis doi: 10.1038/oncsis.2017.4 – volume: 119 start-page: 832 year: 2018 ident: 650_CR80 publication-title: Br. J. Cancer doi: 10.1038/s41416-018-0221-8 – volume: 9 start-page: 22288 year: 2019 ident: 650_CR210 publication-title: Rsc Adv. doi: 10.1039/C9RA90051A – ident: 650_CR127 doi: 10.1186/bcr3480 – volume: 16 start-page: 21 year: 2009 ident: 650_CR155 publication-title: Cancer Cell. doi: 10.1016/j.ccr.2009.04.012 – volume: 22 start-page: 66 year: 2012 ident: 650_CR20 publication-title: Cancer Cell. doi: 10.1016/j.ccr.2012.05.016 – volume: 18 start-page: 572 year: 2016 ident: 650_CR64 publication-title: Nat. Cell Biol. doi: 10.1038/ncb3341 – volume: 171 start-page: 1545 year: 2017 ident: 650_CR96 publication-title: Cell doi: 10.1016/j.cell.2017.10.037 – volume: 52 start-page: 1683 year: 2011 ident: 650_CR45 publication-title: J. Lipid Res. doi: 10.1194/jlr.M012195 – volume: 9 start-page: 230 year: 2006 ident: 650_CR70 publication-title: Prostate Cancer Prostatic Dis. doi: 10.1038/sj.pcan.4500879 – volume: 105 start-page: 317 year: 2013 ident: 650_CR176 publication-title: Biol. Cell. doi: 10.1111/boc.201300011 – volume: 8 start-page: 311 year: 2005 ident: 650_CR34 publication-title: Cancer Cell. doi: 10.1016/j.ccr.2005.09.008 – volume: 159 start-page: 1591 year: 2014 ident: 650_CR217 publication-title: Cell doi: 10.1016/j.cell.2014.11.020 – volume: 39 start-page: 347 year: 2014 ident: 650_CR88 publication-title: Trends Biochem Sci. doi: 10.1016/j.tibs.2014.06.005 – volume: 1851 start-page: 724 year: 2015 ident: 650_CR158 publication-title: Biochim Biophys. Acta doi: 10.1016/j.bbalip.2014.12.011 – volume: 40 start-page: 805 year: 2017 ident: 650_CR172 publication-title: Mol. Cells – volume: 25 start-page: 309 year: 2014 ident: 650_CR208 publication-title: Curr. Opin. Lipidol. doi: 10.1097/MOL.0000000000000091 – volume: 286 start-page: 29568 year: 2011 ident: 650_CR169 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.262816 – volume: 71 start-page: 528 year: 2011 ident: 650_CR216 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-10-2581 – ident: 650_CR13 doi: 10.3390/molecules23081941 – volume: 7 year: 2016 ident: 650_CR174 publication-title: Nat. Commun. doi: 10.1038/ncomms10893 – volume: 169 start-page: 381 year: 2017 ident: 650_CR79 publication-title: Cell doi: 10.1016/j.cell.2017.04.001 – volume: 26 start-page: 6425 year: 2006 ident: 650_CR119 publication-title: Mol. Cell Biol. doi: 10.1128/MCB.01254-05 – volume: 11 start-page: 23 year: 2018 ident: 650_CR180 publication-title: J. Adv. Res. doi: 10.1016/j.jare.2018.03.005 – volume: 43 start-page: 91 year: 2004 ident: 650_CR37 publication-title: Prog. Lipid Res. doi: 10.1016/S0163-7827(03)00039-0 – volume: 1831 start-page: 1533 year: 2013 ident: 650_CR10 publication-title: Biochim Biophys. Acta doi: 10.1016/j.bbalip.2013.02.010 – volume: 8 start-page: 89315 year: 2017 ident: 650_CR139 publication-title: Oncotarget doi: 10.18632/oncotarget.19167 – volume: 351 start-page: 43 year: 2016 ident: 650_CR167 publication-title: Science doi: 10.1126/science.aab2674 – volume: 32 start-page: 807 year: 2017 ident: 650_CR102 publication-title: Cancer Cell. doi: 10.1016/j.ccell.2017.11.011 – volume: 9 start-page: 346 year: 2006 ident: 650_CR121 publication-title: Curr. Opin. Clin. Nutr. Metab. Care. doi: 10.1097/01.mco.0000232893.21050.15 – volume: 67 start-page: 979 year: 2017 ident: 650_CR219 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2017.06.015 – volume: 16 start-page: 732 year: 2016 ident: 650_CR3 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc.2016.89 – volume: 38 start-page: 223 year: 2019 ident: 650_CR24 publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-019-1210-3 – volume: 144 start-page: 106363 year: 2019 ident: 650_CR192 publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/j.prostaglandins.2019.106363 – volume: 16 start-page: 694 year: 2016 ident: 650_CR134 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc.2016.82 – volume: 481 start-page: 380 year: 2012 ident: 650_CR32 publication-title: Nature doi: 10.1038/nature10602 – volume: 559 start-page: 632 year: 2018 ident: 650_CR222 publication-title: Nature doi: 10.1038/s41586-018-0316-7 – volume: 170 start-page: 875 year: 2017 ident: 650_CR141 publication-title: Cell doi: 10.1016/j.cell.2017.07.007 – volume: 2 start-page: 111 year: 2014 ident: 650_CR68 publication-title: Am. J. Clin. Exp. Urol. – volume: 6 start-page: 39891 year: 2015 ident: 650_CR157 publication-title: Oncotarget doi: 10.18632/oncotarget.5359 – volume: 2012 start-page: 539426 year: 2012 ident: 650_CR226 publication-title: J. Nutr. Metab. doi: 10.1155/2012/539426 – volume: 541 start-page: 41 year: 2017 ident: 650_CR17 publication-title: Nature doi: 10.1038/nature20791 – volume: 18 start-page: 1324 year: 2016 ident: 650_CR163 publication-title: Nat. Cell Biol. doi: 10.1038/ncb3441 – volume: 7 start-page: 263 year: 2008 ident: 650_CR197 publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-07-0445 – volume: 56 start-page: 595 year: 2014 ident: 650_CR156 publication-title: Mol. Cell. doi: 10.1016/j.molcel.2014.09.023 – volume: 1063 start-page: 33 year: 2018 ident: 650_CR205 publication-title: Adv. Exp. Med Biol. doi: 10.1007/978-3-319-77736-8_3 – volume: 5 start-page: 1 year: 2017 ident: 650_CR25 publication-title: Cancer Metab. doi: 10.1186/s40170-016-0163-7 – volume: 65 start-page: 556 year: 2013 ident: 650_CR229 publication-title: Nutr. Cancer doi: 10.1080/01635581.2013.775316 – volume: 5 year: 2014 ident: 650_CR54 publication-title: Nat. Commun. doi: 10.1038/ncomms5244 – volume: 30 start-page: 42 year: 2009 ident: 650_CR19 publication-title: Mol. Asp. Med. doi: 10.1016/j.mam.2008.05.005 – volume: 68 start-page: 15 issue: Suppl 3 year: 2016 ident: 650_CR117 publication-title: Ann. Nutr. Metab. doi: 10.1159/000448357 – volume: 284 start-page: 22525 year: 2009 ident: 650_CR120 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109.027748 – volume: 12 start-page: 751 year: 2012 ident: 650_CR148 publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2012.07.006 – volume: 1791 start-page: 501 year: 2009 ident: 650_CR48 publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbalip.2008.10.010 – volume: 9 start-page: 210 year: 2007 ident: 650_CR188 publication-title: Nat. Cell Biol. doi: 10.1038/ncb1534 – volume: 50 start-page: S311 year: 2009 ident: 650_CR1 publication-title: J. Lipid Res. doi: 10.1194/jlr.R800049-JLR200 – volume: 280 start-page: 26483 year: 2005 ident: 650_CR40 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M504041200 – volume: 13 start-page: 1790 year: 2017 ident: 650_CR137 publication-title: Autophagy doi: 10.1080/15548627.2017.1349581 – volume: 5 start-page: 867 year: 2010 ident: 650_CR159 publication-title: Clin. Lipidol. doi: 10.2217/clp.10.67 – volume: 8 start-page: 18 year: 2015 ident: 650_CR227 publication-title: Glob. J. Health Sci. doi: 10.5539/gjhs.v8n7p18 – volume: 36 start-page: 320 year: 2011 ident: 650_CR124 publication-title: Trends Biochem Sci. doi: 10.1016/j.tibs.2011.03.006 – volume: 64 start-page: 353 year: 2015 ident: 650_CR18 publication-title: Diabetes doi: 10.2337/db14-0582 – volume: 1864 start-page: 413 year: 2019 ident: 650_CR218 publication-title: Bba-Mol. Cell Biol. L. – volume: 270 start-page: 25578 year: 1995 ident: 650_CR44 publication-title: J. Biol. Chem. doi: 10.1074/jbc.270.43.25578 – volume: 40 start-page: 445 year: 2008 ident: 650_CR178 publication-title: Exp. Mol. Med. doi: 10.3858/emm.2008.40.4.445 – volume: 249 start-page: 218 year: 2012 ident: 650_CR22 publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2012.01151.x – volume: 98 start-page: 13607 year: 2001 ident: 650_CR42 publication-title: Proc. Natl. Acad. Sci. Usa. doi: 10.1073/pnas.201524598 – volume: 70 start-page: 8117 year: 2010 ident: 650_CR143 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-3871 – volume: 296 start-page: 1655 year: 2002 ident: 650_CR74 publication-title: Science doi: 10.1126/science.296.5573.1655 – volume: 99 start-page: 9498 year: 2002 ident: 650_CR204 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.132128899 – volume: 8 start-page: 29487 year: 2017 ident: 650_CR4 publication-title: Oncotarget doi: 10.18632/oncotarget.15494 – volume: 560 start-page: 499 year: 2018 ident: 650_CR76 publication-title: Nature doi: 10.1038/s41586-018-0343-4 – volume: 8 start-page: 32576 year: 2017 ident: 650_CR85 publication-title: Oncotarget doi: 10.18632/oncotarget.15936 – volume: 64 start-page: 7678 year: 2004 ident: 650_CR78 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-04-2933 – volume: 5 start-page: 592 year: 2014 ident: 650_CR114 publication-title: Protein Cell. doi: 10.1007/s13238-014-0082-8 – volume: 310 start-page: C583 year: 2016 ident: 650_CR108 publication-title: Am. J. Physiol. Cell Physiol. doi: 10.1152/ajpcell.00266.2015 – volume: 151 start-page: 483 year: 2000 ident: 650_CR154 publication-title: J. Cell Biol. doi: 10.1083/jcb.151.3.483 – volume: 8 start-page: 11600 year: 2017 ident: 650_CR132 publication-title: Oncotarget doi: 10.18632/oncotarget.14591 – volume: 121 start-page: 796 issue: Pt 6 year: 2008 ident: 650_CR160 publication-title: J. Cell Sci. doi: 10.1242/jcs.019166 – volume: 35 start-page: 1250 year: 2016 ident: 650_CR94 publication-title: Oncogene doi: 10.1038/onc.2015.179 – volume: 465 start-page: 528 year: 2015 ident: 650_CR194 publication-title: Biochem Biophys. Res Commun. doi: 10.1016/j.bbrc.2015.08.054 – volume: 385 start-page: 454 year: 2009 ident: 650_CR130 publication-title: Biochem Bioph Res Co. doi: 10.1016/j.bbrc.2009.05.085 – ident: 650_CR162 doi: 10.1038/s41467-017-01181-4 – volume: 21 start-page: 3171 year: 2010 ident: 650_CR50 publication-title: Mol. Biol. Cell. doi: 10.1091/mbc.e10-01-0073 – volume: 458 start-page: 762 year: 2009 ident: 650_CR60 publication-title: Nature doi: 10.1038/nature07823 – volume: 76 start-page: 2037 year: 2016 ident: 650_CR144 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-15-1970 – volume: 11 start-page: 427 year: 2016 ident: 650_CR220 publication-title: Curr. Stem Cell Res Ther. doi: 10.2174/1574888X11666151203223512 – volume: 18 start-page: 153 year: 2013 ident: 650_CR26 publication-title: Cell Metab. doi: 10.1016/j.cmet.2013.05.017 – ident: 650_CR28 doi: 10.1038/s41467-018-04987-y – volume: 17 start-page: 1009 year: 2013 ident: 650_CR101 publication-title: Cell Metab. doi: 10.1016/j.cmet.2013.04.010 – volume: 44 start-page: 2144 year: 2012 ident: 650_CR138 publication-title: Int J. Biochem Cell Biol. doi: 10.1016/j.biocel.2012.08.022 – volume: 20 start-page: 137 year: 2019 ident: 650_CR12 publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/s41580-018-0085-z – volume: 9 start-page: 416 year: 2019 ident: 650_CR140 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-18-0567 – volume: 178 start-page: 93 year: 2007 ident: 650_CR61 publication-title: J. Cell Biol. doi: 10.1083/jcb.200703099 – volume: 79 start-page: 443 year: 2016 ident: 650_CR107 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2015.01.019 – volume: 30 start-page: 377 year: 2009 ident: 650_CR185 publication-title: Carcinogenesis doi: 10.1093/carcin/bgp014 – volume: 283 start-page: 2767 year: 2016 ident: 650_CR56 publication-title: FEBS J. doi: 10.1111/febs.13681 – volume: 21 start-page: 1001 year: 2017 ident: 650_CR202 publication-title: Expert Opin. Ther. Tar. doi: 10.1080/14728222.2017.1381087 – volume: 5 year: 2016 ident: 650_CR2 publication-title: Oncogenesis doi: 10.1038/oncsis.2015.49 – volume: 30 start-page: 229 year: 2016 ident: 650_CR105 publication-title: Cancer Cell. doi: 10.1016/j.ccell.2016.06.004 – volume: 6 start-page: 7365 year: 2015 ident: 650_CR214 publication-title: Oncotarget doi: 10.18632/oncotarget.3629 – volume: 25 start-page: 282 year: 2014 ident: 650_CR128 publication-title: Cancer Cell. doi: 10.1016/j.ccr.2014.02.025 – volume: 358 start-page: 157 year: 1992 ident: 650_CR77 publication-title: Nature doi: 10.1038/358157a0 – volume: 136 start-page: 2078 year: 2015 ident: 650_CR200 publication-title: Int J. Cancer doi: 10.1002/ijc.29261 – volume: 14 start-page: 21 year: 2011 ident: 650_CR103 publication-title: Cell Metab. doi: 10.1016/j.cmet.2011.06.002 – ident: 650_CR83 doi: 10.1101/cshperspect.a006783 – volume: 39 start-page: 231 year: 2007 ident: 650_CR113 publication-title: J. Bioenerg. Biomembr. doi: 10.1007/s10863-007-9081-2 – volume: 108 start-page: 2011 year: 2017 ident: 650_CR66 publication-title: Cancer Sci. doi: 10.1111/cas.13339 – volume: 177 start-page: 23 year: 2017 ident: 650_CR199 publication-title: Pharmacol Therapeut. doi: 10.1016/j.pharmthera.2017.02.021 – volume: 568 start-page: 566 year: 2019 ident: 650_CR212 publication-title: Nature doi: 10.1038/s41586-019-1094-6 – volume: 22 start-page: 427 issue: 4 year: 2016 ident: 650_CR73 publication-title: Nature Medicine doi: 10.1038/nm.4055 – volume: 3 start-page: 582 year: 2003 ident: 650_CR170 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1143 – volume: 142 start-page: 1390 year: 2015 ident: 650_CR171 publication-title: Development doi: 10.1242/dev.121723 |
| SSID | ssj0009087 |
| Score | 2.728427 |
| SecondaryResourceType | review_article |
| Snippet | A common feature of cancer cells is their ability to rewire their metabolism to sustain the production of ATP and macromolecules needed for cell growth,... |
| SourceID | pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 4 |
| SubjectTerms | 1-Phosphatidylinositol 3-kinase 631/67/2327 631/80/86/2365 AKT protein Biomedical and Life Sciences Biomedicine Cancer Cancer Research Carcinogenesis - drug effects Carcinogenesis - metabolism Cell survival Drug Resistance Epidemiology Epigenome Fatty acids Fatty Acids - metabolism Humans Lipogenesis - drug effects Macromolecules Metabolism Metastases Molecular Medicine Neoplasms - drug therapy Neoplasms - metabolism Oncology Oxidation Phosphatidylinositol 3-Kinases - metabolism Phosphoinositide-3 Kinase Inhibitors - therapeutic use Proto-Oncogene Proteins c-akt - antagonists & inhibitors Proto-Oncogene Proteins c-akt - metabolism Review Review Article Signal transduction Signal Transduction - drug effects TOR protein TOR Serine-Threonine Kinases - antagonists & inhibitors TOR Serine-Threonine Kinases - metabolism Tumor microenvironment Tumor Microenvironment - drug effects Tumors |
| Title | Reprogramming of fatty acid metabolism in cancer |
| URI | https://link.springer.com/article/10.1038/s41416-019-0650-z https://www.ncbi.nlm.nih.gov/pubmed/31819192 https://www.proquest.com/docview/2342388285 https://www.proquest.com/docview/2323479158 https://pubmed.ncbi.nlm.nih.gov/PMC6964678 |
| Volume | 122 |
| WOSCitedRecordID | wos000507526800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1532-1827 dateEnd: 20211231 omitProxy: false ssIdentifier: ssj0009087 issn: 0007-0920 databaseCode: M7P dateStart: 20190101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1532-1827 dateEnd: 20211231 omitProxy: false ssIdentifier: ssj0009087 issn: 0007-0920 databaseCode: 7X7 dateStart: 20190101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1532-1827 dateEnd: 20211231 omitProxy: false ssIdentifier: ssj0009087 issn: 0007-0920 databaseCode: BENPR dateStart: 20190101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Proquest Nursing & Allied Health Source customDbUrl: eissn: 1532-1827 dateEnd: 20211231 omitProxy: false ssIdentifier: ssj0009087 issn: 0007-0920 databaseCode: 7RV dateStart: 20190101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: Proquest Public Health Database customDbUrl: eissn: 1532-1827 dateEnd: 20211231 omitProxy: false ssIdentifier: ssj0009087 issn: 0007-0920 databaseCode: 8C1 dateStart: 20190101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RFiEuvB-BdhUkTiCrjvOwfapK1YoLq1UFaG-R7dhqpG62bFIk-uvxONmslopeevHFzsOe8Xhe_gbgY-qctswJ4mRhSZY4RzQzlHDDqSqMZlyqUGyCT6diPpezweHWDmmVa5kYBHW1NOgjP2QIVScQb-3o6hfBqlEYXR1KaOzAHqIkpCF1b7YB3aWix8xEd5xkY1QzFYdtlnhVxBvSeAc_p-Rm-1y6pWzezpn8J3AazqOzp_edyTN4Mmii8XHPOs_hgW1ewKNvQ6z9JVCvm_fJWwv_A_HSxU513Z9YmbqKF7bz3HNZt4u4bmKDrLN6BT_OTr-ffCVDfQVi8rToSJUZb1dbL2eSSuVM6SoRlpu8sN4mM0rnGXfSqzDKKCeVcFLTNKUuUdwYmjmdvobdZtnYtxALKiuVqExopzNt0C4StrK548KwVPEI6Hp1SzOAj2MNjMsyBMFTUfYEKT1BSiRIeRPBp_GRqx55467B--u1LodN2JabhY7gw9jttw_GRFRjl9c4huFd2iQXEbzpKTx-zYs7b81KFgHfov04AKG5t3ua-iJAdBey8CeQf-fnNZdsfuu_k3h39yTew2OGxn7w_-zDbre6tgfw0Pzu6nY1gR1-_hPbOQ-t8K04SSaw9-V0OjufhJ3xF9WCEG8 |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoALb0qggJHgAorqOA_bB4QQULVqu0KooN6C7dgiUjfbblJQ-6P4jYzzWi0VvfXAOY5jZ17-ZsYzAC9j57RlToROZjZMIudCzQwNueFUZUYzLlXbbIJPJuLgQH5egd_DXRifVjnoxFZRFzPjfeQbzJeqE77e2ruj49B3jfLR1aGFRscWO_b0F0K2-u32R6TvK8Y2P-1_2Ar7rgKhSeOsCYvEIJq0KF1RoVKmdBEJy02aWUQiRuk04U6i4VZGOamEk5oi5neR4sbQxOkY570CV1GPRz6FjH_5tijyS0VXo9O7_yQbo6ix2KiTCI8-CNz9nf-UhmfLdvDc4fZ8juZfgdrW_m3e_t_-3B241Z-0yftONO7Ciq3uwfW9PpfgPlDEHl1y2hQ3TGaOONU0p0SZsiBT26B0HJb1lJQVMV405g_g66Ws9yGsVrPKPgIiqCxUpBKhnU608bhP2MKmjgvDYsUDoAM1c9MXV_c9Pg7zNsgfi7xjgBwZIPcMkJ8F8Hp85airLHLR4PWBtnmvZOp8QdgAXoyPUT34mI-q7OzEj2H-rnCUigDWOo4av4bqHNG6ZAHwJV4bB_jS48tPqvJHW4I8kxlaWJzzzcCVi2X9cxOPL97Ec7ixtb-3m-9uT3aewE3mHRutr2sdVpv5iX0K18zPpqznz1qpI_D9spn1D1ukazA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgiouvAuBAkaCCyhax3nYPiCEWlZUhVUPIPUWbMcWkbrZsklB7U_j1zHOa7VU9NYD5ziOnflm7HkDvIyd05Y5ETqZ2TCJnAs1MzTkhlOVGc24VG2zCT6biaMjebgBv4dcGB9WOcjEVlAXC-Nt5BPmS9UJX29t4vqwiMO96buTH6HvIOU9rUM7jQ4iB_bsF6pv9dv9PaT1K8amH77sfgz7DgOhSeOsCYvEoGZpkdOiQqVM6SISlps0s6iVGKXThDuJh7gyykklnNQU9X8XKW4MTZyOcd5rcJ3HiGKfpb67Ci-RVHT1Or0pULLRoxqLSZ1EeA1CJd7n_6c0PF8_Ey9cdC_Ga_7ltG3Pwunt__kv3oFb_Q2cvO9Y5i5s2OoebH3uYwzuA0WdpAtam-PmycIRp5rmjChTFmRuG-Sa47Kek7IixrPM8gF8vZL1bsNmtajsIyCCykJFKhHa6UQbrw8KW9jUcWFYrHgAdKBsbvqi6773x3HeOv9jkXdgyBEMuQdDfh7A6_GVk67iyGWDdwY6573wqfMVkQN4MT5GseF9Qaqyi1M_hvkc4igVATzs0DV-DcU8avGSBcDXcDcO8CXJ159U5fe2NHkmMzx5cc43A0JXy_rnJh5fvonnsIUYzT_tzw6ewE3m7R2tCWwHNpvlqX0KN8zPpqyXz1oGJPDtqrH6B-CDc4s |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reprogramming+of+fatty+acid+metabolism+in+cancer&rft.jtitle=British+journal+of+cancer&rft.au=Koundouros+Nikos&rft.au=Poulogiannis+George&rft.date=2020-01-01&rft.pub=Nature+Publishing+Group&rft.issn=0007-0920&rft.eissn=1532-1827&rft.volume=122&rft.issue=1&rft.spage=4&rft.epage=22&rft_id=info:doi/10.1038%2Fs41416-019-0650-z&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0920&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0920&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0920&client=summon |